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Abstract 
Periplasmic nitrate reductase from Sulfurospirillum barnesii is representative of the 
distinct branch of epsilonproteobacteria periplasmic nitrate reductases.  The gene 
encoding the active subunit of S. barnesii’s periplasmic nitrate reductase (napA) was 
successfully cloned into the vector pET101/D/TOPO.  Constructs were made both with 
and without the sequence coding for the periplasmic signal sequence.  Preliminary 
expression and purification experiments were performed with limited success.  The DNA 
encoding the periplasmic signal sequence proved necessary for expression.  Even with 
the signal sequence coding region, protein expression was limited.  The low levels of 
expression appeared due to product degradation during cell growth.  Purification was 
incomplete, with both low recovery levels and significant contamination. 
 
 
 
 
 
 
 
 
 1 
Introduction 
 
The Nitrogen Cycle 
 Nitrogen is an essential element for all living organisms.  Nitrogen is found in the 
environment both as a part of organic molecules (such as protein) and as inorganic 
species, primarily nitrate, nitrite, ammonia, and nitric oxide.  The inorganic portion of the 
global nitrogen cycle is driven primarily by microorganisms, which convert inorganic 
nitrogen from one form to another (figure 1).                                                                                                
 Human activities can have a significant impact on the nitrogen cycle.  Every year, 
tons of fixed-nitrogen fertilizers, mostly in the form of ammonia, are applied to 
agricultural land.  Much of the ammonia applied is quickly transformed to nitrate by 
nitrifying bacteria.  Since nitrate is susceptible to denitrification (transformation to N2) 
and to leaching, the transformation has attracted considerable attention as a source of 
fertilizer loss in intensive agricultural systems.  The leaching of nitrate into terrestrial and 
aquatic ecosystems can lead to environmental problems. Excess nitrogen in the 
environment can lead to acidification of soils, eutrophication of water bodies, and, at high 
levels, toxicity in plants and animals (5).   
Excess nitrate in drinking water can result in methymoglobinemia (blue baby 
syndrome).  Studies have also linked nitrate consumption to non-hodgekin’s lymphoma, 
several forms of cancer, and adverse reproductive outcomes (spontaneous abortions, 
stillbirths, premature births, and retarded intrauterine growth).  Thyroid hypertrophy, 
childhood type I diabetes, and increased blood pressure have also been linked to nitrate 
consumption, though further study is needed to confirm these effects (40).     
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Figure 1: The inorganic nitrogen cycle.  Transformation of inorganic nitrogen from one 
species to another is performed primarily by microbes: eukaryotic organisms absorb 
nitrogen primarily as nitrate (NO2-) and ammonia (NH4+).  Source: Stolz and Basu (31) 
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 Because of these problems, considerable attention has been given to nitrate 
leaching from agricultural systems and the fate of nitrate in the environment.  Models 
have been developed to explore nitrate leaching (20), and nitrate concentration in 
groundwater, both at local and national scales (25).  These models consider microbial 
denitrification and uptake by plants as the major routes of attenuation in nitrate loaded 
environments.   
Dissimilatory nitrate reduction to ammonia (DNRA) represents an alternate fate 
for nitrate in the environment.  DNRA transforms nitrate to ammonia via nitrite.  This 
pathway tends to occur in anaerobic, carbon enriched environments (37).  In certain 
environments, DNRA has been shown to be the dominant form of nitrate transformation: 
Christensen et al (8) demonstrated that reduction to ammonia was the dominant pathway 
in carbon and nitrogen enriched sediments taken from beneath trout cages in marine fish 
farms.  In an aquatic environment, reduction to ammonium can lead to further 
eutrophication, as opposed to denitrification, which removes nitrogen from the system.   
  DNRA is typically carried out as part of an electron transport chain in anaerobic 
respiration by bacteria.  The first step is performed by nitrate reductase.  Bacterial nitrate 
reductases are generally divided into three categories: membrane bound respiratory (Nar), 
cytoplasmic assimilatory (Nas), and periplasmic (Nap) nitrate reductases (31). 
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Periplasmic nitrate reductase 
 Periplasmic nitrate reductase is found in a wide variety of bacteria, including 
many Proteobacteria, as well as in other gram negative and gram positive bacteria (see 
appendix 1 for a full list of bacteria with nap homologues). 
 When the different types of nitrate reductase were first classified, membrane 
bound nitrate reductase was considered the main respiratory nitrate reductase, while 
periplasmic nitrate reductase was thought to function mainly in nitrate dissimilation to 
oxidize excess reducing equivalents.  Rhodobacter sphaeroides DSM 158 is an example 
of an organism that supports this hypothesis: it contains Nap, yet cannot assimilate or 
respire nitrate (24).  However, further research showed that Nap does, in fact, act in 
respiration in many cases.  A number of nitrate respiring organisms contain only Nap, 
while others, such as Escherichia coli, contain both Nap and Nar systems.  When the nar 
genes are knocked out in E. coli K-12, the mutant is still able to respire nitrate using Nap 
(30).  Work by Wang et al (39) showed that in E. coli, the two systems are 
complimentary: the nap operon is expressed at low nitrate concentrations, while nar is 
expressed at higher nitrate concentrations.    
 Periplasmic nitrate reductase has been characterized in a number of organisms.  
The structures of several periplasmic nitrate reductases from Desulfovibrio desulfuricans 
(10),  R. sphaeroides (2), and E. coli (18) have been solved thus far.  Nap from 
Paracoccus pantotrophus has also been well characterized through EXAFS (4). 
All prokaryotic nitrate reductases, including the periplasmic nitrate reductases, are 
molybdoenzymes belonging to the dimethyl sulfoxide (DMSO) reductase family.  They 
contain an iron sulfur cluster [Fe4-S4], and a molybdenum atom coordinated to the 
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molybdopterin guanine dinucleotide (MGD) molybdenum cofactor at the active site.  
Eukaryotic organisms do not have the MGD cofactor: eukaryotic nitrate reductases 
contain a molybdopterin (MPT) molybdenum cofactor, and belong to the sulfite oxidase 
family, (figure 2) (34). 
Protein folding and cofactor incorporation of periplasmic nitrate reductase occurs 
in the cytoplasm.  In most cases, the folded protein contains a twin argenine motif on the 
N-terminus, which facilitates its translocation to the periplasm via the twin argenine 
translocator system (41).  Once NapA has been transported to the periplasm, it complexes 
with NapB (except in D. desulfuricans, which contains only the monomeric protein, and 
possibly Desulfitobacterium hafniense, whose genome does not appear to contain a napB 
gene).   
The nap operon is highly variable between bacteria, not only in the gene order but 
also in which genes are present.  The order and composition of the nap operon in 
representative organisms is shown in figure 3.  In addition to the catalytic subunit NapA, 
which is always present, and NapB, which is present in most organisms studied, the 
operon can contain napC, D, F, G, H, K, and L.  Three of these are involved in electron 
transfer: the c-type tetra-heme membrane anchored protein NapC, and the ferrodoxins 
NapG and NapH.  The rest are either involved in protein assembly and translocation, or 
are of unknown function (12).   
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Figure 2: Active site of the SO and DMSO families.  All known prokaryotic nitrate 
reductases belong to the DMSO family (A and B).  Eukaryotic nitrate reductases belong 
to the SO family (C). Source: Tavares et al (34). 
 
 
 
 
Figure 3: Gene composition and order of selected bacteria.  In addition to the catalytic 
subunit (NapA), most organisms contain the NapB subunit and a host of related enzymes 
that assist in electron transport and protein folding. The members of the 
epsilonproteobacteria (campylobacter and wollinella) have a unique gene order.  Source: 
Gonzalez (12) 
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In addition to the differences in the nap operon, napA from different sources 
shows considerable variation, both in terms of sequence homology and in the structure of 
the enzyme.    For example, Dd Nap is a monomeric protein, while the other Naps 
characterized to date occur as a heterodimer of NapA and NapB.  The Rhodobacter Nap 
heterodimer is a robust unit: remaining intact throughout purification, whereas NapA and 
B in E. coli are only weakly associated, and separate during purification (18). 
The high level of genetic and biochemical diversity in the Nap system suggests 
that periplasmic nitrate reduction functions in different ways in different organisms.  Two 
alternate electron pathways have been proposed for periplasmic nitrate reduction based 
on the composition of the operon (12).  The variation in NapA also suggests differences 
in the way the protein functions to reduce nitrate.   
Thus far, the Naps that have been well studied have come from the alpha-delta- 
and gamma  clades of proteobacteria.  No Nap from an epsilonproteobacteria has been 
well characterized.   Analysis of the gene sequence shows that napA from the 
epsilonproteobacteria form a distinct group apart from the naps of other proteobacteria, 
as illustrated in figure 4.  Given the diversity of Naps from the other groups, this genetic 
diversity suggests that the epsilon Naps may be significantly different from other Naps in 
their structure and mode of action. The characterization of a Nap from an 
epsilonproteobacteria can be expected to yield valuable information that will aid in 
understanding the diversity of the Nap system.   
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Figure 4: Distance tree of Naps in Proteobacteria (next page). Light blue 
=alphaproteobacteria, green=betaproteobacteria, yellow=gammaproteobacteria, 
pink=eubacteria, red=enterobacteria, dark blue=epsilonproteobacteria. The 
epsilonproteobacteria form a distinct branch of the tree.  Source: NCBI database protein 
BLAST search.  The tree was built with a maximum sequence difference of 0.75.     
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Epsilonproteobacteria 
   The epsilonproteobacteria are a metabolically and ecologically diverse group.  
The class contains only one order, Campylobacterales, which divided into three families: 
campylobacteraceae, helicobacteracea, and nautiliaceae.  Members of 
campylobacteraceae and helicobacteracea are found in soil, aqueous environments, and 
in humans and animals: many members in both families are pathogens: Campylobacter 
species can cause acute enteritis and reproductive disorders, while Helicobacter species 
have been linked to the formation of peptic ulcers (22).  The nautiliaceae are anaerobic 
marine thermophiles.   
 Campylobacter and Helicobacter are the best known genera in the 
epsilonproteobacteria.  Both contain many pathogenic species, and have been well 
studied for this reason.  The helicobacteracea family contains the Helicobacter and 
Wolinella genera.  Many members of the Helicobacter are pathogenic: Wolinella contains 
only one species, which is found in cow rumens, and is not pathogenic. 
 In addition to Campylobacter, the Campylobacteraceae family contains the 
Arcobacter and Sulfurospirillum genera.  The Arcobacter are diverse, with species 
ranging from pathogens to plant-associated nitrogen fixers (11). 
 
Sulfurospirillum barnesii 
 The Sulfurospirillum genus is most closely related to Campylobacter, and consists 
of free living species found in freshwater and marine environments.  They are micro 
aerobic, and can use succinate, fumarate, formate, malate, and pyruvate as electron 
donors during respiration (some species can use lactate as well).  As acceptors, different 
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members of the genus can use elemental sulfur, sulfite, thiosulfate, trimethylamine oxide, 
Fe(III), DMSO, arsenate, selenate, nitrite, and nitrate.  The genus currently has six known 
species, including Sulfurospirillum barnesii. 
 S. barnesii was placed in the genus only after 16S RNA analysis (32).  It was 
isolated from a selenate contaminated freshwater marsh in Nevada, and originally given 
the genus name Geospirillum (26).  It is gram negative, 0.3 µm wide and 1-2 µm long, 
with a polar flagellum.  Its optimal growth is at 33oC, pH 7.5, 0.05% NaCl.  It can use 
elemental sulfur, thiosulfate, trimethylamine oxide, Fe(III), arsenate, selenate, nitrite, and 
nitrate as its electron acceptors.  Selenate is reduced to elemental selenium, and nitrate is 
reduced to ammonium (32).  
 S. barnesii was originally discovered due to its production of elemental selenium, 
which makes it of interest from the environmental perspective.  However, the nitrate 
reductase from S. barnesii is of particular interest due to its relationship to the pathogenic 
members of the epsilonproteobacteria.  S. barnesii nap operon is in the order 
napAGHBFLD.  This order is similar to that in other epsilonproteobacteria: 
Campylobacter jejuni lacks napF, but otherwise has the same order.  The napA of S. 
barnesii has a sequence significantly different from that of previously characterized naps, 
and similar to those in other epsilonproteobacteria.  Characterization of a periplasmic 
nitrate reductase from the epsilonproteobacteria would add to our understanding of the 
Nap enzyme, and also to our understanding of the pathogenic species in the class.    
 One method of gaining a better understanding of the function of NapA in S. 
barnesii is through mutagenesis studies.  Hettmann et al (14) were able to demonstrate 
the importance of a lysine residue at the active site of the NapA from Ralstonia eutropha.  
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The residue is highly conserved not only in periplasmic nitrate reductases, but in formate 
dehydrogenases as well.  Hettman et al replaced the lysine residue with both uncharged 
and charged residues to determine its function in the active site.  They found that 
replacing the lysine with a charged residue resulted in a mutant with only 23% of wild 
type activity.  Such studies can answer questions about the mode of action of the catalytic 
site, dimerization, and coordination of cofactors. 
 As S. barnesii is not amenable to genetic manipulation, site directed mutagenesis 
requires transfer of the napA gene into a different system for mutagenesis and expression.  
Several systems can be used for genetic manipulation and heterologous expression: the 
most common method is insertion of a plasmid into E. coli.  
    
Heterologous expression of molybdoenzymes 
A number of groups have been successful in over expressing molybdoenzymes in 
bacterial hosts.  The systems used are variable, including expression in Rhodobacter (19), 
and expression of a eukaryotic nitrate reductase in the yeast Pichia pastoris (38).  
Expression in E. coli has also been used, with varying success. E. coli has several 
advantages over other host organisms:  it is easy to genetically manipulate, and it can 
synthesize the MGD cofactor, which eukaryotic systems cannot do.    
 Over-expression of proteins in E. coli is a well established technique in molecular 
biology, and has been successful in many cases.  However, heterologous expression, 
especially of active enzyme, can pose a challenge.  In order to express functional NapA 
from S. barnesii in E. coli, several possible issues must be considered.  As discussed 
above, NapA is a molybdoenzyme in the DMSOR family, and contains both an MGD 
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cofactor and an iron-sulfur cluster.  If a functional enzyme is to be obtained, the protein 
must be correctly assembled with the MGD cofactor and the iron sulfur cluster.       
 
The molybdenum cofactor in E. coli 
In order to manufacture the active form of NapA, the molybdenum cofactor must 
be present.  Eukaryotic molybdoenzymes use the molybdopterin cofactor .  Most 
prokaryotic molybdoenzymes, including NapA, require a modified form, the 
molybdopterin guanine dinucleotide (MGD) cofactor (13).  In E. coli, MPT is 
synthesized first, then converted to MGD by MobA (figure 5)(36).   
Although many of E. coli’s molybdoenzymes are anaerobic respiratory enzymes, 
the MGD cofactor is made under both aerobic and anaerobic conditions (1).  
Theoretically, this should allow heterologous expression of molybdoenzymes in E. coli 
under aerobic or anaerobic conditions.   
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Figure 5: Modification of the MPT cofactor to form MGD.   MobA adds the 
nucleotide to the MPT cofactor to form MGD.  Most prokaryotic enzymes use the MGD 
cofactor.  Most cofactor present in E. coli is in the MGD form.  Source: Temple, 
Rajagopalan (36). 
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Previous molybdoenzyme expression studies 
 Most molybdoenzymes expressed in E. coli to date have been either homologous 
expression of E. coli proteins or expression of eukaryotic members of the sulfite oxidase 
family.  While the enzymes of this family are related to those in the DMSOR family, the 
sulfite oxidase family contains the molybdenum in an MPT, rather than an MGD 
cofactor.  In E.coli, MPT is a precursor to MGD; many of the eukaryotic studies use E. 
coli strains that express higher levels of MPT.  
Temple, Graf, and Rajaagopalan (35) achieved high level expression of a 
eukaryotic molybdoenzyme, human sulfoxide reductase, with an average yield of 15.1 
mg/L.  They used a vector with a trc promoter and a 6x his tag on the N-terminus.  They 
used the E. coli strain MC4100 and its derivative TP1000, which lacked MobA, which 
converts the MPT cofactor to MGD.  The cells were grown aerobically in Mo 
supplemented LB and expressed with 20uM IPTG at 30oC for 16-18 hrs.  Their 
experiments with BL21(DE3) gave a higher total protein yield, but a much lower activity 
levels.  The reason for the low activity may be related to the lack of the MPT cofactor: in 
E. coli strains containing MobA, most of the MPT is converted to MGD.   
 Pollock et al (28) expressed assimilatory nitrate reductase from spinach in both 
BL21(DE3) and TP1000.  Expression levels were similar in both strains: about 1.5 mg/L 
for both strains.  TP1000 activity levels were higher, but this can be attributed to the 
higher concentration of MPT cofactor due to the mobA deletion.  The pET28 system was 
used in BL21(DE3), which incorporated a His tag on the N-terminus.  Expression was 
performed aerobically in Terrific Broth for 16-18 hrs at room temperature and 
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anaerobically in “anaerobic media” containing NZ amine, salts, and fumaric acid at room 
temperature for 24 hrs. 
 Heterologous expression of prokaryotic molybdoenzymes in E. coli has been 
successful in only two cases.  The first is biotin sulfoxide reductase from Rhodobacter 
spharoides.  Pollock and Barber (27) were able to recover about 0.125 mg/L using a 
pGex vector in E. coli strain JM109 and a 4 hour induction at 24oC in LB.  The recovered 
enzyme had a high rate of cofactor incorporation and good activity.  However, E. coli 
also possesses a biotin sulfoxide reductase with a very similar sequence, which may 
facilitate expression.   
The second example of a successfully over expressed molybdoenzyme in E. coli 
is also from Rhodobacter: Hilton, Temple, and Rajaagopalan (15) expressed R. 
sphaeroides Dimethyl Sulfoxide Reductase in E. coli strain BL21(DE3) using pET-28 
and pET-29 expression systems.  They determined that the optimal expression of active 
enzyme was obtained by removing the periplasmic signal sequence and adding an N-
terminal 6X his tag.  The optimal expression conditions were growth in M9ZB broth 
supplemented with fumaric acid, glucose, Na2MoO4, and 80 µM IPTG, anaerobically at 
room temperature for 24 hrs.  Under these conditions, they recovered about 0.5 mg/L 
active protein.  The published results do not show a gel of the induction, only western 
blot analysis.   
Both successfully expressed proteins came from R. sphaeroides.  Attempted 
expression with proteins from other sources has been less successful.  Baas and Retey (3) 
attempted expression of pyrogallol-phloroglucino transhydroxylase from Pelobacter 
acidigallici using both pT-7 and a pQE 30 expression systems.  In both cases, they 
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obtained high levels of protein yield – up to 30% of total cellular protein.  Unfortunately, 
all the peptide was in inclusion bodies which could only be solubilized by boiling in 1% 
SDS.  Attempts to extract active enzyme by gentler methods or refold the enzyme with 
the cofactor failed.  They concluded that homologous expression may be a more 
promising route.     
 
Expression of epsilonproteobacteria proteins 
 Like expression of molybdoenzymes, expression of enzymes from 
epsilonproteobacteria has been successful in several cases.  McClain and Cover (23) were 
able to successfully express a vacoulating toxin from Helicobacter pilori using a pET 
vector with a T7 expression system.  The induction was performed at room temperature 
in Terrific Broth and 250 µM IPTG induction for 20 hours.  The level of induction was 
not quantitatively determined; the expressed protein was detected by immunoblotting and 
activity assays.   
 Roncarati et al (29) were also successful in expressing a Helicobacter protein.  
They were able to heterologously express the membrane associated HrcA repressor 
protein in E. coli BL21 using the pET expression system.  They were initially 
unsuccessful due to difficulties with toxicity and solubility.  These problems were 
overcome by adding a heat shock step of 90 minutes at 42oC prior to a 4 hour induction in 
LB with 1 mM IPTG.   
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The pET expression system 
The pET vectors 
 The Champion pET expression system from Invitrogen is based on the expression 
vector developed by Studier (33).  The pET vectors contain the T7lac promoter, which is 
recognized by the strong bacteriophage T7 RNA polymerase.  This promoter is capable 
of producing large amounts of protein when the polymerase is present.  In the pET 
expression systems provided by Invitrogen (Carlsbad, California), T7 polymerase is 
provided by the host strain.  The presence of the polymerase in the expression strain leads 
to some basal expression of the gene under T7 control.  To reduce basal expression, pET 
vectors include a lac operator sequence downstream from the T7 promoter.  The operator 
serves as a binding site for the lac repressor (encoded by lacI in the vector, figure 6), 
which reduces basal transcription of the gene of interest in the absence of IPTG.   
  The pET vectors also contain an antibiotic resistance marker conferring either 
kanamycin or ampicillin resistance, and one or more tags to identify and purify the 
expressed protein.  pET101/D-TOPO contains a V5 epitope and a 6x histidine tag 
designed to be transcribed on the C-terminus of the gene product for antibody detection 
and affinity purification (Figure 6).  
 
Directional TOPO cloning 
 The Invitrogen TOPO cloning system uses Topoisomerase I from Vaccinia virus.  
Topoisomerase cleaves the phosphodiester backbone and binds to the DNA after the 
sequence 5′-CCCTT.  The binding can be reversed by the 5′ hydroxyl of an incoming 
DNA strand.   
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 The TOPO cloning vectors contain the 5′-CCCTT sequence on both sides of the 
cloning site.  Topoisomerase I binds to both sequences, which prevents self annealing of 
the linear vector.  Topoisomerase I is then displaced by an incoming blunt-end PCR 
product.  Because the vector does not close on itself, the majority of the plasmids taken 
up by the competent cells contain an insert, which eliminates the need for blue/white 
screening.   
 The vector also contains a 3′-GTGG overhang on the front end of the cloning site.  
The PCR product is the designed with a CACC sequence at the 5′ end.  During the 
cloning reaction, the vector overhang anneals to the complimentary sequence of the 
incoming PCR product, stabilizing the insert in the desired orientation.  Under optimal 
conditions, this method can achieve greater than 90% efficiency of cloned products in the 
correct orientation.   
 
E .coli expression and the BL21 Star (DE3) expression strain  
 BL21 Star (DE3) is an E. coli B/r strain and has the genotype F- ompT hsdSB (rB-
mB-) gal dcm rne131 (DE3).  DE3 indicates the presences of the λDE3 lysogen, which 
carries the gene for T7 RNA polymerase under the control of the IPTG inducible lacUV5 
promoter.  The T7 polymerase gene is inserted into the phages int gene, preventing its 
entry into the lytic cycle.   
 The BL21 strain does not contain the lon protease, and also carries a mutation in 
the outer membrane protease ompT.  In addition, BL21 Star carries a mutated rne gene, 
which lacks mRNA degrading capabilities.   
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Figure 6: Map of the pET101 TOPO vector from Invitrogen.  The T7 promoter is 
tightly regulated by the lacO operator directly downstream, which is regulated by the 
product of lacI, also encoded by the plasmid.  The Topoisomerase at the cloning site 
allows for fast cloning reactions.  If the cloned gene is inserted in the correct frame and 
without a stop codon, transcription will continue, and the resulting peptide will contain 
the V5 epitope and a tag of six histidine residues at the C-terminus for identification and 
purification.  Source: Invitrogen manual (16) 
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The pLysS plasmid 
 The BL21 Star (DE3) pLysS strain contains the pLysS plasmid, which encodes 
the gene for T7 lysozyme.  The lysozyme binds to T7 RNA polymerase, inhibiting 
transcription and reducing basal expression levels of the gene of interest.  If the gene in 
question is toxic, using the pLysS strain will allow the cells to grow to the point where 
induction is possible.  However, the presence of T7 lysozyme will reduce overall 
expression of the gene as well. 
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Objectives 
 Periplasmic nitrate reductases from the epsilonproteobacteria form a distinct 
group within the proteobacteria.  No member of this group has been characterized to date.  
The NapA gene from   S. barnesii is a good model for the periplasmic nitrate reductase 
because it is closely related to the other epsilonproteobacteria, the organism is easier to 
culture than other members of the class, and the entire sequence is known. 
 The objective of this project is to clone and heterologously express the S. barnesii 
NapA in E. coli in order to develop a system for investigating the active site through site-
directed mutagenesis.  As previous studies have been successful in expressing similar 
enzymes in E. coli, we hypothesis that expression of functional NapA from S. barnesii is 
possible in E. coli.       
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Materials and methods 
NapA primer design 
 The primers used to amplify napA from S. barnesii were designed based on the 
complete sequence obtained by previous members of the Stolz lab.  The forward primer 
was designed to start after the GC cleavage site of the periplasmic signal sequence.  
Hybridization was designed to begin with the AAG codon, 29 codons after the gene’s 
start codon, in order to preserve the reading frame.  The reverse primer began with the 
codon immediately preceding the stop codon.  This allowed the c-terminal his tag and V5 
epitope to be transcribed.    
 
Nucleic acid extraction from Ses-3 
 20 ml of a three-day culture of S. barnesii Ses-3 grown in nitrate media was spun 
down at 7000 x g, then rinsed and resuspended in 1.6 ml lysis buffer (50mM EDTA, 
0.1M NaCl, pH 7.5).  180µl lysozyme (0.1g/ml in lysis buffer) was added, and the cells 
were incubated at 37ΟC (no shaking) for 10 min.  120 µl of 20% SDS was added, and the 
tube was mixed by inverting.  2 ml of Tris-buffered phenol (pH7.9) was added, and the 
tube was mixed, then separated by centrifuging at 5,000 rpm for 5 minutes.  The aqueous 
layer was removed, and the phenol extraction was repeated.  A third phenol extraction 
was performed if needed (i.e. if the lysate did not look clear).  The DNA was precipitated 
by adding 80 µl of 5 M NaCl and 4 ml EtOH.  The mixture was incubated at -20ΟC for 3 
minutes, then spun at 12,000 x g at 4ΟC.  The pellet was washed with 70% EtOH, then 
allowed to air dry for 1 hour, until the pellet looked dry.  The DNA was resuspended in 
500 µl sterile water.  
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Amplification of the napA gene 
The PCR reaction was performed using the following reaction mix:  
 10-50 ng DNA 
 25 pmol primer 1 (1 µM in final reaction) 
 25 pmol primer 2 (1 µM in final reaction) 
 2.5 µl 10x Pfu Turbo reaction buffer 
 0.5 µl dNTPs (nucleotide mix: 10mM each of dATP, dGTP, dTTP, dCTP) 
 0.5 µl Pfu Turbo enzyme (2.5U) 
  sterile water to a final volume of 25 µl 
Polymerase and nucleotides were from Stratagene (LaJolla, California).  Primers were 
from IDT (Coralville, Iowa).  The reaction was carried out using a Techne Cycler.  The 
cycling parameters were: 
Heated lid 110ΟC 
94ΟC    7 min 
_____________________________ 
94ΟC    1 min  
51ΟC    1 min                         X 35 
72ΟC    2 min 35 sec 
_____________________________ 
75ΟC    7 min 
4ΟC     final hold 
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The efficiency of the reactions was confirmed by running 5 µl mixed with 5µl 2x dye on 
an agarose gel (0.8% agarose in TAE buffer, poured with 2 µl 10 mg/ml ethidium 
bromide solution/100 ml gel). 
Ligation 
The PCR product obtained through the method outlined above was ligated into the 
pET101/D/TOPO vector using the protocols provided with the Invitrogen pET TOPO kit 
(16).  5-10 ng of the PCR reaction was added in a volume of 1-4 µl to 1 µl of salt solution 
and 1µl of TOPO vector, provided with the kit.  Sterile water was added to a final volume 
of 6 µl.  The reaction mixture was incubated for 15 minutes at room temperature.  The 
reaction was used immediately or stored at –20ΟC until transformation. 
 
Transformation 
 3 µl of the ligation reaction described above was added to a tube of OneShot 
top10 chemically competent cells.  The reaction was incubated for 15 minutes on ice, 
then placed in a 42ΟC water-bath for 30 seconds.  250 µl of room temperature SOC media 
(provided with the kit) was added and the tube was incubated at 37ΟC, 200 rpm, for one 
hour.  100 µl of cells were then spread on each of two amp selective plates and 100 µl 
was spread on an LB plate to verify cell viability.  The plates were incubated at 37ΟC 
overnight.  Colonies were then transferred with a sterile toothpick to a fresh amp 
selective plate with a numbered grid.   
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Plasmid extraction 
 Plasmid extraction was performed using the Promega Wizard SV DNA column 
purification kit from Promega (Madison, Wisconsin).  Single or pooled colonies were 
grown overnight in 10 ml LB-amp media.  The culture was then spun down at 7,000 rpm 
for 5 minutes.  The pellet was then resuspended in 250 µl of cell resuspention buffer.  250 
µl of lysis buffer was added, and the mixture was incubated for 3-5 minutes.  10 µl of 
alkaline protease was added, followed by another 5 minute incubation period.  
Neutralization solution was then added, and the tubes were spun at 12,000 rpm for 15 
minutes.  The supernatant was removed to a fresh tube and spun a second time under the 
same conditions.  The supernatant from the second spin was added to the column.  The 
column was washed twice with wash buffer, and the plasmid was eluted with 100 µl 
nuclease free water.  Concentration and purity of the plasmid was determined using 260 
and 280 nm spectrophotometer readings: a 260/280 ration of 1.7-1.9 indicated a relatively 
pure sample.    
 
Restriction digest 
 To verify the identity and orientation of the insert, restriction digest with sacI was 
performed on the purified plasmids.  Reagents were obtained from Promega.  9 µl of 
purified DNA (100-130 ng/µl) was combined with 2 µl buffer (buffer J, 10 x), 0.2 µl 
BSA (10mg/ml), 1 µl SacI (10U/µl), and 7.8 µl sterile water.  The reaction was incubated 
in a 37ΟC water bath for 1-2 hour, then frozen.  4 µl of 6x DNA loading dye (Promega) 
was added, and the samples were run on a 0.8% agarose gel. 
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PCR confirmation 
 To confirm the orientation of the insert, directional PCR was used.  The forward 
primer was designed to hybridize with the plasmid about 40 bases before the cloning site, 
and the reverse primer was designed to hybridize about 460 bases from the 5’ end of the 
napA gene.  Buffer, nucleotides, and Taq were from Promega.  The reaction mixture was 
as follows:  
25-65 ng DNA,  
1 µl Nucleotide mix,  
10 µl 2.5 x buffer,  
1 µl of the forward primer 
1 µl reverse primer (~20mM concentration)  
0.25 µl Taq polymerase (10 units/µl)  
sterile water to a final volume of 25 µl.   
 
The cycling parameters were as follows: 
Heated lid 110ΟC 
_____________________________ 
95ΟC     30 sec  
50ΟC    30 sec                         X 35 
70ΟC    1 min 
_____________________________ 
72ΟC    75min 
4ΟC     final hold 
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An alternate procedure was also used using PCR RedMix from GeneChoice (Fredrick, 
Maryland).  A single colony was picked from the plate with a sterile toothpick, and 
spread inside a PCR tube.  1 µl of each primer was added, 12.5 µl of RedMix, and water 
to 20 µl. The reactions were heated at 96oC for 10 minutes before using the program 
described above. 
 
DNA Sequencing 
 Primers for sequencing were designed using MacVec.  The reactions were 
performed using the BigDye system from Applied Biosystems (Foster City, California). 
The following reaction mixture was used: 
15-20 nmol  primer  
200-300 ng plasmid  
2 µl BigDye solution  
6 µl 2.5X buffer  
sterile water to 20 µl.  
The reaction was performed on a DNA Engine Dyad Peltier thermal cycler from 
MJ Research (Waltham, Massachusetts) under the following conditions: 
 
Heated lid 100oC 
95oC   1 min (ramp to 95o at 1oC/min) 
______________________________________ 
95oC   30 sec (ramp to 95oC at 1oC/min) 
50oC    5 sec (ramp to 50oC at 1oC/min)    X 74 
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60oC   4 min (ramp to 60oC at 1oC/min) 
_______________________________________ 
10oC   Hold 
 The completed reaction was then passed through a Centricep column (Princeton 
separations, Adelphia, NJ) filled with 800 µl Sephadex G-50 (Sigma) suspended in sterile 
nanopure water at a concentration of 0.7 g/ml. The columns were allowed to drain, the 
spun at 750 x g for 2 minutes to remove interstitial fluid.  The sequencing reaction was 
loaded onto the column and spun at 750 x g for 2 minutes.  The collected sample was 
then dried in a SpeedVac until dry, resuspended in 20 µl di formamide (Sigma), heated to 
95oC for 2 minutes, and sequenced using a 3100-Avant Genetic Analyzer.  Sequences 
were examined in Chromas, and aligned to the known napA sequence using ClustalW.  
 
Insertion of Kanamycin resistance  
 Kanamycin was inserted to replace ampicillin in the construct because it is a more 
reliable antibiotic.  Replacement was preformed using phage transformation with the λ 
phage λNk1105 (λcI857, b522, Pam80, Δkan, ptac-rtnpase).  A stock of λ lysate was 
used to make 7 dilutions from 10 to 10-7 in TMG buffer (appendix 2).  0.1 ml of each 
dilution was added to 0.1 ml of an overnight culture of E. coli LE392.  The mixture was 
incubated at RT for 10 minutes, then 2.5 ml of molten top agar was added and the 
mixture was poured over a TB1 agar plate.  The plates were incubated overnight and 
37C.  The next day, individual plaques were added to 0.1 ml fresh overnight LE392 
culture. 5 ml TBMM broth was added, and the tubes were incubated with rotating at 37C 
for 4-6 hours, until the cells began to lyse.  10 drops of chloroform were added, the tubes 
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were spun down for 20 minutes at 35,000 rpm, and the supernatant was transferred to a 
sterile glass tube and 10 more drops of chloroform was added.  The lysate titer was tested 
by rediluting and spotting 10 µl of each dilution onto TB1 plates overlaid with top agar 
containing 0.1 ml overnight culture of LE392.  The next morning, the plaques were 
examined, and the titer was estimated by determining which dilution yielded a countable 
number of plaques. 
 The fresh lysate was then used to infect Top10 cells containing the construct.  
Equal amounts of overnight cells and lysate were mixed and incubated at 37oC for 30 
minutes.  The reaction was diluted 1:5 in LB broth and incubated with shaking for 30 
minutes.  The cells were then spun down to concentrate them, resuspended in 400 µl LB 
broth, and spread on two LB-kan plates.  The plates were incubated overnight. 
 The next morning, the colonies were removed from the plate by washing with 7 
ml of 50 mM sodium citrate in LB broth.  The resulting cells were spun down, and the 
plasmid was extracted as described above.  The plasmids were then retransformed into 
Top10 cells, and grown on LB-kan plates.  Single colonies were selected and spotted onto 
LB-kan and LB-amp plates with a sterile toothpick.  Colonies that were kanamycin 
resistant and ampicillin sensitive were selected, and confirmed by performing PCR on the 
insert and through restriction analysis, as described above. 
 
Site Directed Mutagenesis 
 Site directed mutagenesis was performed using the QuikChange Site directed 
mutagenesis kit from Stratagene.  Mutagenesis primers were designed using Stratagene’s 
primer design program (http://www.stratagene.com/tradeshows/feature.aspx?fpId=118).  
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The resulting primers were purchased from IDT DNA, with standard desalting.  
Mutagenesis was carried out according to the protocol provided by Stratagene.  The 
following reaction mixture was used: 
5 µl of 10 x reaction buffer 
10 ng plasmid 
125 ng primer 1 
125 ng primer 2 
1 µl dNTP mix  
3 µl QuikSolution 
Sterile nanopure water to a final volume of 49 µl 
1 µl PfuUltra HF DNA polymerase (2.5 U/µl) 
The PCR cycling parameters were: 
Heated lid 110oC 
95oC   1 minute 
____________________________ 
95oC   50 seconds 
60oC   50 seconds                      X17 
68oC   8.5 minutes 
____________________________ 
68oC   7 minutes 
10oC   hold 
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The resulting PCR product was digested with Dpn I restriction enzyme to digest the 
template plasmid.  1 µl of Dpn (10 U/µl) was added to the PCR mix, and the reaction was 
incubated at 37oC for 1 hour.  The digest was then transformed into XL10-Gold 
Ultracompetent Cells.  45 µl of cells were aliquoted into prechilled BD Falcon 
polypropelene tubes BD biosciences, San Jose, California).  2 µl of β-ME mix was added 
and the cells were incubated on ice for 10 minutes with swirling every 2 minutes. 2 µl of 
the digested plasmid reaction was added, and the cells were incubated on ice for 30 
minutes.  The cells were then heat shocked at 42oC for 30 seconds, placed back on ice for 
2 minutes, and 500 µl of 42oC SOC media was added to the tube.  The reaction was then 
incubated at 37oC for 1 hour with shaking.  250 µl of the reaction was plated on each of 2 
Amp selective plates.  The plates were incubated overnight.  The next morning, 4 
individual colonies were streaked out on fresh Amp plates and cultured overnight in 
liquid media.  Plasmid was isolated from the colonies, and the mutated site was 
sequenced using the appropriate primer.  
 
Pilot Protein Expression 
 To express the NapA in E. coli, the construct was transformed into BL21 Star  
(DE3).  The competent cells were thawed on ice, and 5-10 ng of plasmid was added to 
the vial.  The cells were incubated for 10 minutes, then heat shocked in a 42ΟC water bath 
for 30 seconds.  The tubes were transferred to ice for several minutes, then 250 µl of 
S.O.C. solution was added, and the tubes were incubated with shaking for 30-60 minutes.  
The entire reaction was transferred to 10 ml LB broth with antibiotic and grown 
overnight at 37oC with shaking.  
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The next morning, 500 µl of the overnight culture was transferred to 10 ml of 
fresh LB with antibiotic.  The culture was grown until the OD600 was about 0.8.  The 
culture was then divided into two 5 ml cultures, and one was induced by adding IPTG 
(Promega) to a final concentration of 1 mM.  The cultures were grown for 3-6 hours with 
300 µl samples taken every half hour.  The samples were brought to a volume of 1 ml, 
and the absorbance was taken at OD600. The absorbance was used to standardize the 
amount of sample run on the gel: a reading of 1.0 corresponded to 10 µl loaded on the 
gel.  The samples were then spun at maximum speed for 20 seconds, and the supernatant 
was poured off.  The cell pellet was resuspended in 50 µl 10 mM Tris pH 7.5 and 50 µl 
Laemmli sample buffer from BioRad (Hercules, California), and boiled at 90oC for 5 
minutes.  If necessary, the samples were pipetted with a 200 µl pipette to cleave the 
nucleic acids.  The samples were then run on a polyacrylamide gel as described below.  If 
the OD of the samples was low, the pellet was resuspended in 50 µl sample buffer (no 
Tris), and an OD of 0.5 corresponded to 10 µl loaded on the gel. 
 
Scaled-up protein expression  
BL21 Star (DE3) cells were transformed and grown overnight as described for the 
pilot expression.  The next morning, 1 ml of the overnight culture was transferred to a 
flask with 50 ml LB containing the appropriate antibiotic.  The culture was grown to an 
OD600 of 0.9, and induced with 1 mM IPTG.  The induced culture was grown for 2.5 
hours, and harvested by spinning at 5200 x g for 7 minutes.  The pellet was rinsed once 
and resuspended in 4 ml native purification buffer (100 mM NaCl 500 mM phosphate), 
and French pressed to lyse the cells.  Protease inhibitor cocktail from Sigma-Aldrich was 
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added at a concentration of 1 mg/ml of culture.  Glycerol was added to a final 
concentration of 5% and the lysate was stored at -80oC.  
 
Anaerobic Expression 
 Anaerobic expression was conducted in LB media degassed with N2 and enriched 
with 20 mM lactate, 14 mM DMSO, and 1 mM sodium molybdate.  The supplements 
were added after autoclaving.   
 BL21 Star (DE3) cells containing the insert were transformed as described above, 
and grown aerobically overnight.  The next morning, 500 µl of overnight culture was 
inoculated in 5 ml LB media and grown anaerobically to an OD600 of 1.  The culture was 
then diluted 1:20 in the anaerobic media.  The appropriate antibiotic and was also added.  
The cultures were induced IPTG at a final concentration of 50 µM immediately after 
inoculation.  The bottles were then shaken at room temperature. For the pilot inductions, 
1 ml samples were taken at 16, 18, and 24 hours, and processed as described above for 
the aerobic pilot expression. 
 
Chloramphenicol pulse-chase 
 Cells were induced as described above for pilot expression.  After 2 hours, 
chloramphenicol was added to a final concentration of 200µl/ml, and incubation 
continued at 37oC with shaking for 4 more hours.  Samples were taken as described 
above for pilot induction. 
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SDS-PAGE protein gel  
 SDS-PAGE gels were run using the BioRad (Hercules, California) system.  
Protein samples were diluted 1:1 with Laemmli sample buffer containing β-
mercaptoethanol, then incubated at 85ΟC for 5 minutes (if whole cells were used, samples 
were prepared as described above).  The samples were then loaded on a BioRad precast 
gel (12% Tris-HCl) and run in a Tris-glycine buffer with 10% SDS at 70-75 volts until 
the dye front reached the bottom of the gel.  The gel was then stained in coommassie for 
2 hours – overnight and destained in 10% acetic acid at least 4 hours, or used in a western 
blot transfer. 
 
Western Blotting 
 Western blots were performed using the BioRad system and 0.45 µm NitroBind 
nitrocellulose membrane from Osmonics (Minnetonka, Minnesota).  The gel was run as 
described above, then equilibrated in the transfer buffer (192 mM glycine, 24 mM Tris, 
and 10% methanol) to remove the SDS.  The membrane was hydrated in water, and then 
equilibrated in transfer buffer.  The sandwich was assembled using thin blotting paper, 
and run at 250mA for 20-30 minutes.  Transfer was verified by staining for 2-4 minutes 
with Ponceau S solution from Sigma (0.1% Ponceau S in 5% acetic acid), then rinsing 
with water and observing the bands.  The blot was then destained in water until the bands 
were no longer visible and incubated in killer filler 1-2 hrs, then in V5-antibody 
(Invitrogen) diluted 1:2,000 in Killer Filler overnight.  The next morning, the blot was 
washed three times in Tween-Tris-buffered saline (TTBS) for 5 min each and twice in 
Tris-buffered Saline (TBS) for 5 minutes each.  The blot was then equilibrated in 
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carbonate buffer for 2-3 minutes, and developed with 5-bromo-4-chloro-3-indolyl 
phosphate (BCIP) and Nitro-blue tetrazolium in carbonate buffer.  The blots were imaged 
using an HP scanner. 
 
ProBond Column purification 
 Protein purification was performed under native conditions according to the 
Invitrogen protocol (17) with minor modifications.  The lysates were prepared as 
described above in native binding buffer (50mM NaH2PO4, 100 mM NaCl).  The lysate 
from about 25 ml of cells was used in the column.  Columns were prepared by adding 2 
ml of Probond resin from Invitrogen to a column and rinsing once with 6 ml sterile 
deionized water and twice with 6 ml native binding buffer.  The lysate was brought to a 
volume of 8 ml with native binding buffer and added to the column.  The column was 
then incubated for 30 min – 1 hour at room temperature with rotation to keep the resin 
suspended.  After incubation, the column was allowed to settle through gravity or by 
centrifuging for 1 minute at 750 x g.  If centrifuging was used, the resin that collected on 
the side of the tube was allowed to settle for about a minute.  The lysate was removed by 
pipetting, and the column was rinsed 4 times with 20 mM imidazole in native binding 
buffer, then eluted in 1.5 ml fractions with 250 mM imidazole in native binding buffer.  
The lysate, washes, and fractions were run on a protein gel for analysis.  If activity was to 
be preserved, the protein containing fractions were immediately dialyzed 1:2,000 in 
native binding buffer.    
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Bradford Assay 
 The Bradford Assay was performed using BioRad’s QuickStart Bradford protein 
assay kit.  20 µl of sample was added to 1 ml of room temperature dye, vortexed, and 
incubated at room temperature for 5 minutes.  The mixture was read at an OD of 595.  A 
standard curve was prepared using BioRad's pre-diluted samples.  The resulting curve 
and equation is shown in figure 7.   
  
The Methyl Viologen Redox/ Greiss Assay 
 To measure the activity of nitrate reductase in cell lysates, a modified version of 
the activity assay described by MacGregor (21) was used.  Reaction mixtures of 0.9 mM 
nitrate and nitrite in 3 mM methyl viologen, 50 mM Tris buffer (pH 7.1) were prepared 
and thoroughly degassed with N2.  Sodium dithionite was added anaerobically to a final 
concentration of 1.14 mM to reduce the methyl viologen.  100 µl of cell lysate or purified 
protein was added to 2.8 ml of each reaction mixture.  The reaction was allowed to 
continue for 1 hour, then 200 µl of the reaction was extracted for the Greiss assay.  200 µl 
of 1% sulfanilamide in 5% phosphoric acid was added to each tube.  The tubes were 
incubated 5 minutes in the dark, and 200 µl of 0.1% NEDD in water was added.  The 
color was measured at 540 nm.      
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Figure 7: Standard curve BSA protein concentration vs. OD.  The equation is 
displayed on the graph, and was used to estimate protein concentration in samples.
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Results 
Primer design 
 The initial primers were designed to remove the signal sequence at the 5′ end of 
the gene, and the stop codon at the 3′ end.  The resulting primers are shown in figure 8. 
The forward primer was labeled SeNapAF200.2 and the reverse was SeNapAR200.3.  
The melting temperatures were 63.8oC and 52.6oC, respectively.  SeNapAF200.2 was 
designed with the CACC sequence for TOPO cloning and the ATG start codon, since the 
genes original start codon was not amplified.  Table 1 lists of the primers developed. 
 
Amplification and cloning of Ses-3 napA. 
 The primers were successful in amplifying a 2.7 kb fragment from Ses-3 genomic 
DNA (figure9a). The product was confirmed as napA through a second amplification step 
using internal primers specific to napA (figure 9b).  The internal amplification yielded a 
2.5 kb band, the expected size based on primer location (see appendix 3 for position of 
primers).   
 Based on the results described above, the 2.7 kb PCR product was used for 
cloning with no further purification.  The resulting transformation produced several 
hundred clones.  Of these, 106 were analyzed, and two contained the correct insert based 
on the PCR and restriction enzyme analyses. 
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Table 1: Primers designed for amplification, sequencing and mutagenesis. 
Primer Sequence Tm 
Amplification primers 
SeNapAF200.2 CACCATGAAGGCTGCTGGTGAGCA 63.8
SeNapAR200.1 GGCTTTATAGAGCTTAACAGCA 52.6
SeNapAF200.3 CCACATGTCTCTTTCAAGAAGAGA 57.9
SeNapAR201 CGAAAACCAGCCTTCATCAT 53.3
Plasmid primers  
topvecT7 ATCGGTGATGTCGGCGAT 56.6
TopPETvecF1 GCGCATAACAATTCCCCTCT 54.7
Sequencing Primers  
SeNapAF202 AAGGGTATGCGGCTGCTAAG 57.5
SeNapAF203 CCTTTGGTATTGATGAGCC 50.8
SeNapAF204 CGGACCTTGAAATCATCTTCTCTC 55.2
SeNapAF205 TATGGTATGCGAACCGAG 51.5
SeNapAR206 GGGGCGTCGGTGTGTAAAGGT 61.3
SeNapAF207 CCAAGATACTGCCAATGC 51.1
SeNapAF208 GGCAGTGGGTTGAACTTTC 54.2
SeNapAF209 AAGTCTTTGGTGATGCTCG 52.7
SeNapAF210 TAAAGAGACCCAATGGCG 52.1
SeNapAF211 TGTGTTAGAGCACTGGCATAG 54.5
Mutagenesis primers  
SeNapAmutF1 TACGGTAATGCCGAGCGACGCACACAACACTGGAGAC 69.1
SeNapAmutF2 GTCTCCAGTGTTGTGTGCGTCGCTCGGCATTACCGTA 69.1
SeNapAmutF3 AGGAGCCCTTCACCATGAAAGCTGCTGGTGA 67.4
SeNapAmutR3 TCACCAGCAGCTTTCATGGTGAAGGGCTCCT 67.4
SeNapAmutF4 GGAAGCTAATTGGAAATGGGATAAAGCTGTTTGCCGTT 64.2
SeNapAmutR4 AACGGCAAACAGCTTTATCCCATTTCCAATTAGCTTCC 64.2
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 The PCR analysis is shown in Figure 10.  To verify the correct orientation of the 
insert, a primer pair designed to amplify 30bp of the vector and 460 bp of the 5’ end of 
the insert were designed.  The resulting product (fig 10a) shows a product running at a 
low molecular weight: gels of the pooled fractions verified that the product was ~500 bp.  
The original primers were used to verify the size of the insert (fig 10b).   
Finally, restriction digest with sacI was used as a further confirmation of the 
direction and size of the insert.  The pET101 plasmid has a sacI restriction site just after 
the cloning site.  napA has a restriction site 1.14 Kb from the 3’ end of the gene (figure 
11).  The predicted result of the restriction digest, therefore, is a band at ~7.4 kb (5.7 kb 
plasmid + 1.7 kb NapA) and a second band at 1.14 kb (NapA fragment).  
The resulting restriction digest is shown in figure 12.   Based on the restriction 
analysis as well as the PCR reaction described above, C3 and C42 both appeared to 
contain the construct in the correct orientation. 
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Figure 8: Design of Ses-3 primers.  The forward primer was designed to start precisely 
one codon after the signal sequence cleavage site, to preserve the reading frame.  The 
reverse primer was designed to exclude the stop codon and preserve the reading frame to 
allow for expression of the 6x His tag and V5-epitope 
 
 
 
 
Figure 9: a) PCR reaction using SES-3 genomic DNA and primers SeNapAF200.2 
and SeNapAR200.1.  b) PCR reaction of amplified product from figure 9a using 
internal napA primers cjNapAF8 and SeNapR11.  
Cleavage site 
a.                       b. 
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Figure 10: PCR of cloned plasmids using SeNapAF200.2 and SeNapAR200.1.  lane: 
1=C3, 2=41, 3=42.  C3 and C42 appear to have the insert, while C41 is negative. b. PCR 
of cloned plasmids using TopPEVecF1 and SeNapAR201.  lane: 1=C3 amplified with 
RedMix, 2=C1, 3= C1, 4=C2, 5= C3, 6=C42.  Lanes 2-6 were amplified using Taq 
polymerase. 
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Figure 11: Diagram of pET101/D-TOPO with NapA insert and restriction 
sites.  The pET101/D-TOPO plasmid has a sacI restriction site 6 bases after the 
cloning site.  napA has a sacI restriction site that yields a 1.4kb and a 1.3kb 
fragment.  
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Figure 12: sacI restriction digest of constructs. Lane 1=uncut 
plasmid, 2=C43, 3=C42, 4=C41, 6=C3, 7=C2, 8=C1.  Both C42 and C3 
show a digested fragment at ~1.3 Kb, and a second fragment at 7.4 Kb. 
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Sequencing 
 The primers designed for sequencing using MacVec are listed in table 1 and 
shown in appendix 3. 
 The resulting alignments are shown in figure 13.  The primers were successful in 
sequencing nearly the entire sequence of both inserts, with the exception of one region 
later in the gene (bases 1560-1620 in figure 13).  There are several mismatches with 
predicted sequence at the beginning of both constructs: however, the constructs agree 
with each other, and an ORF translation (shown in appendix 4) yielded the known protein 
sequence. There are no deletions or insertions evident in the well sequenced areas.   
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Figure 13 : Sequence alignment for C3 and C42.  The sequencing verified that the 
cloning site was intact and in frame.  There several mismatches early on in the gene.  
However, two of them do not affect the protein sequence, and the others match up to the 
protein sequence data, suggesting that the published sequence was faulty.  The one region 
with gaps (bases 1560-1620) is due to sequencing problems: the region has few suitable 
primer sites, and the data available from the sequencing reactions is uncertain. 
 
vector      CCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAAT 120 
C42         ------------------ATCTCGATCCCGCGAA-TTAATACGACTCACTATAGGGGAAT 41 
                              **************** ************************* 
C3          CCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAAT 66 
                            ************************************************************ 
 
Vector      TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA 180 
C42         TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA 101 
            ************************************************************ 
C3          TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA 126 
            ************************************************************ 
                    Cloning site 
napA        GGAGCCCTTCACCATGAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGAAATGGGATAA 240 
C42         GGAGCCCTTCACCATGAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGCGATGGGACAA 161 
            *************************************************  ****** ** 
C3          GGAGCCCTTCACCATGAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGCGATGGGACAA 186 
            *************************************************  ****** ** 
 
napA        GGCTGTTTGCCGTTTCTGTGGTACCGGTTGTGGTATTATGGTGGCGACCAAAGAGGGTAA 300 
C42         ATCTGTGTGCCGTTTCTGTGGTACCGGTTGTGGTATTATGGTGGCGACCAAAGAGGGTAA 221 
              **** ***************************************************** 
C3          ATCTGTGTGCCGTTTCTGTGGTACCGGTTGTGGTATTATGGTGGCGACCAAAGAGGGTAA 246 
              **** ***************************************************** 
 
napA        AATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGACTTAACTGTATCAA 360 
C42         AATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGACTTAACTGTATCAA 227 
            ************************************************************ 
C3          AATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGACTTAACTGTATCAA 199 
            ************************************************************ 
 
napA        AGGCTATTTTAACGCCAAAATTATGTACGGTGCGGACAGATTAAAACAACCCCTTCTTCG 420 
C42         AGGCTATTTTAACGCCAAAATTATGTACGGTGCGGACAGATTAAAACAACCCCTTCTTCG 287 
            ************************************************************ 
C3          AGGCTATTTTAACGCCAAAATTATGTACGGTGCGGACAGATTAAAACAACCCCTTCTTCG 259 
            ************************************************************ 
 
napA        TATGAACGATAAAGGTGAGTTTGACAAAAAAGGTCAGTTTAAACCTGTTTCATGGAAGCG 480 
C42         TATGAACGATAAAGGTGAGTTTGACAAAAAAGGTCAGTTTAAACCTGTTTCATGGAAGCG 347 
            ************************************************************ 
C3          TATGAACGATAAAGGTGAGTTTGACAAAAAAGGTCAGTTTAAACCTGTTTCATGGAAGCG 319 
            ************************************************************ 
 
 
napA        TGCGTTTGATGAGATGGAAAAACACATCAAAGCAGCACTTAAAGTGGGTGGGCCAGAGGC 540 
C42         TGCGTTTGATGAGATGGAAAAACACATCAAAGCAGCACTTAAAGTGGGTGGGCCAGAGGC 407 
            ************************************************************ 
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C3          TGCGTTTGATGAGATGGAAAAACACATCAAAGCAGCACTTAAAGTGGGTGGGCCAGAGGC 379 
            ************************************************************ 
 
napA        GATTGGTGTGTTTGGTTCAGGTCAGTACACCATTCAAGAAGGGTATGCGGCTGCTAAGAT 600 
C42         GATTGGTGTGTTTGGTTCAGGTCAGTACACCATTCAAGAAGGGTATGCGGCTGCTAAGAT 467 
            ************************************************************ 
C3          GATTGGTGTGTTTGGTTCAGGTCAGTACACCATTCAAGAAGGGTATGCGGCTGCTAAGAT 436 
            ************************************************************ 
 
napA        GATGAAGGCTGGTTTTCGTGCCAACGGAATTGATCCTAATGCACGTCACTGTATGGCTTC 660 
C42         GATGAAGGCTGGTTTTCGTGCCAACGGAATTGATCCTAATGCACGTCACTGTATGGCTTC 527 
            ************************************************************ 
C3          GATGAAGGCTGGTTTTCGTGCCAACGGAATTGATCCTAATGCACGTCACTGTATGGCTTC 496 
            ************************************************************ 
                                                                             
napA        AGCGGTTGCAGGCTTTATGCAAACCTTTGGTATTGATGAGCCAGCAGGGTGTTATGATGA 720 
C42         AGCGGTTGCAGGCTTTATGCAAACCTTTGGTATTGATGAGCCAGCAGGGTGTTATGATGA 99 
            ************************************************************ 
C3          AGCGGTTGCAGGCTTTATGCAAACCTTTGGTATTGATGAGCCAGCAGGGTGTTATGATGA 115 
            ************************************************************ 
 
napA        TATTGAAATTACCGATACTATCATTACATGGGGCGCTAATATGGCAGAGATGCACCCGAT 780 
C42         TATTGAAATTACCGATACTATCATTACATGGGGCGCTAATATGGCAGAGATGCACCCGAT 159 
            ************************************************************ 
C3          TATTGAAATTACCGATACTATCATTACATGGGGCGCTAATATGGCAGAGATGCACCCGAT 175 
                             ************************************************************ 
 
napA        TTTATGGTCACGTGTGAGTGATAGAAAACTTACCTCACCTGATCGTGTCAAAATCGTTAA 840 
C42         TTTATGGTCACGTGTGAGTGATAGAAAACTTACCTCACCTGATCGTGTCAAAATCGTTAA 219 
            ************************************************************ 
C3          TTTATGGTCACGTGTGAGTGATAGAAAACTTACCTCACCTGATCGTGTCAAAATCGTTAA 235 
                             ************************************************************ 
 
napA        CCTCTCAACCTATACCCACCGCTGTTCTGACCTTGCGGACCTTGAAATCATCTTCTCTCC 900 
C42         CCTCTCAACCTATACCCACCGCTGTTCTGACCTTGCGGACCTTGAAATCATCTTCTCTCC 279 
            ************************************************************ 
C3          CCTCTCAACCTATACCCACCGCTGTTCTGACCTTGCGGACCTTGAAATCATCTTCTCTCC 295 
            ************************************************************ 
 
napA        AAGTACCGATTTGGCAATTTGGAACTATATCGCTCGTGAGATTGTCTACAATCATCCAGA 960 
C42         AAGTACCGATTTGGCAATTTGGAACTATATCGCTCGTGAGATTGTCTACAATCATCCAGA 339 
            ************************************************************ 
C3          AAGTACCGATTTGGCAATTTGGAACTATATCGCTCGTGAGATTGTCTACAATCATCCAGA 355 
                          ************************************************************ 
 
napA        AGCGATTGATTGGGATTTTGTTAAGAAAAATACCATTTTTACAACAGGTTTTGCGAACAT 1020 
C42         AGCGATTGATTGGGATTTTGTTAAGAAAAATACCATTTTTACAACAGGTTTTGCGAACAT 399 
            ************************************************************ 
C3          AGCGATTGATTGGGATTTTGTTAAGAAAAATACCATTTTTACAACAGGTTTTGCGAACAT 235 
                             ************************************************************ 
 
napA        TGGTTATGGTATGCGAACCGAGGCTGAGGCTAAAAAATTAGGCTATTCTGCAAAAGAACT 1080             
C42         TGGTTATGGTATGCGAACCGAGGCTGAGGCTAAAAAATTAGGCTATTCTGCAAAAGAACT 309 
            ************************************************************ 
C3          TGGTTATGGTATGCGAACCGAGGCTGAGGCTAAAAAATTAGGCTATTCTGCAAAAGAACT 295 
            ************************************************************ 
 
napA        TGAAGTCATTAAAAAAGAAGATGCCAAAGTCATTTCTGAAAAAGAAGCTCCAGGTCTTGC 1140 
C42         TGAAGTCATTAAAAAAGAAGATGCCAAAGTCATTTCTGAAAAAGAAGCTCCAGGTCTTGC 369 
            ************************************************************ 
C3          TGAAGTCATTAAAAAAGAAGATGCCAAAGTCATTTCTGAAAAAGAAGCTCCAGGTCTTGC 171 
            ************************************************************ 
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napA        ACACTTAGGTGTCAAAGCAGGCGATGTTATGAAAATGGACAAAGCAGATGCAGCTGGTGC 1200 
C42         ACACTTAGGTGTCAAAGCAGGCGATGTTATGAAAATGGACAAAGCAGATGCAGCTGGTGC 63 
            ************************************************************ 
C3          ACACTTAGGTGTCAAAGCAGGCGATGTTATGAAAATGGACAAAGCAGATGCAGCTGGTGC 231 
            ************************************************************ 
 
napA        ACATTGGGAAATTAGCTTTGAAGATTTCAAAAAAGCTTTAGAGCCTTATACGCTGGAGTA 1260 
C42         ACATTGGGAAATTAGCTTTGAAGATTTCAAAAAAGCTTTAGAGCCTTATACGCTGGAGTA 123 
            ************************************************************ 
C3          ACATTGGGAAATTAGCTTTGAAGATTTCAAAAAAGCTTTAGAGCCTTATACGCTGGAGTA 207 
            ************************************************************ 
 
napA        TGTCGCAAAGATTTCTAAAGGTAATCCCGATGAAAAACTAGAAGATTTCAAAGTTAAACT 1320 
C42         TGTCGCAAAGATTTCTAAAGGTAATCCCGATGAAAAACTAGAAGATTTCAAAGTTAAACT 183 
            ************************************************************ 
C3          TGTCGCAAAGATTTCTAAAGGTAATCCCGATGAAAAACTAGAAGATTTCAAAGTTAAACT 267 
            ************************************************************ 
 
napA        TCAAGAACTTGCCAATCTTTATATTGAAAAAAATAGAAAAGTCGTTAGTTTCTGGACAAT 1380 
C42         TCAAGAACTTGCCAATCTTTATATTGAAAAAAATAGAAAAGTCGTTAGTTTCTGGACAAT 243 
            ************************************************************ 
C3          TCAAGAACTTGCCAATCTTTATATTGAAAAAAATAGAAAAGTCGTTAGTTTCTGGACAAT 327 
            ************************************************************ 
 
napA        GGGCTTTAACCAGCACCAAAGAGGCACATGGGTTAATGAGCAGTCCTACATGGTTCACTT 1440 
C42         GGGCTTTAACCAGCACCAAAGAGGCACATGGGTTAATGAGCAGTCCTACATGGTTCACTT 303 
            ************************************************************ 
C3          GGGCTTTAACCAGCACCAAAGAGGCACATGGGTTAATGAGCAGTCCTACATGGTTCACTT 387 
            ************************************************************ 
 
napA        CCTTTTAGGCAAACAAGCCAAACCAGGTGATGGAGCGTTTTCTCTTACAGGACAGCCAAG 1500               
C42         CCTTTTAGGCAAACAAGCCAAACCAGGTGATGGAGCGTTTTCTCTTACAGGACAGCCAAG 444 
            ************************************************************ 
C3          CCTTTTAGGCAAACAAGCCAAACCAGGTGATGGAGCGTTTTCTCTTACAGGACAGCCAAG 447 
            ************************************************************ 
 
napA        TGCCTGTGGAACTGCACGTGAAGTAGGTACCTTTACACACCGACTCCCCNCAGATATGGA 1560 
C42         TGCATGTGGAACTGCACGTGAAGTAGGTACCTTTACACACCGACTCCCCGCAGATATGGA 493 
            *** ********************************************* ********** 
C3          TGCATGTGGAACTGCACGTGAAGTAGGTACCTTTACACACCGACTCCCCGCAGATATGGA 507 
            *** ********************************************* ********** 
 
napA        TGTTTCCATTCCCAAACATAGAGAAGTGA GTGAAAAAATTTGGAAGCTACCTGCTGGCAC 1620 
C42         TGTTTCCATTCCCAAACATAGAGAAGTGA GTGAAAAANTTTGGAAGCTACCTGCTGGCAC 553 
            ***************************** ******** ********************** 
C3          TTTT CCNTTCCCCNACATAGAAGAAGTGNGTGAAAAA-TTTGGAAGCTACCTGCTG---- 90 
            * ** ** *****  ************** *************************** 
 
napA        ACTCAACCCAATGGGTTACCAACACATTATGAACATNCACCGTCAAATTGAGAGTGGAAA 1680 
C42         ACTCAACCCAATGGGTTACCAACACATTATGAACATTCACCGTCAAATTGAGAGTGGAAA 69 
            ************************************ *********************** 
C3          ACTCAACCCAATGGGTTACCAACACATTATGAACATTCACCGTCAAATTGAGAGTGGAAA 78 
            ************************************ *********************** 
 
napA        AATCAAATTTGCATGGGTAAACGTCTGTAATCCTTACCAAGATACTGCCAATGCCAATCA 1740 
C42         AATCAAATTTGCATGGGTAAACGTCTGTAATCCTTACCNAGATACTGCCNATGCCAATCA 129 
            ************************************** ********** ********** 
C3          AATCAAATTTGCATGGGTAAACGTCTGTAATCCTTACCAAGATACTGCCAATGCCAATCA 138 
            ************************************************************ 
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napA        CTGGATTAAAGCAGCACGAGAGCTCGATAACTTTATTGTTTGTTCCGATGCGTATCCTGG 1800 
C42         CTGGATTAAAGCAGCACGAGAGCTCGATAACTTTATTGTTTGTTCCGATGCGTATCCTGG 189 
            ************************************************************ 
C3          CTGGATTAAAGCAGCACGAGAGCTCGATAACTTTATTGTTTGTTCCGATGCGTATCCTGG 198 
            ************************************************************ 
 
napA        GATTTCTGCCAAAGTATCTGACCTTATTCTTCCCTCAGCAATGATTTATGAAAAATGGGG 1860 
C42         GATTTCTGCCAA-GTATCTGACCTTATTCTTCCCTCAGCAATGATTTATGAAAAATGGGG 119 
            ************* ********************************************** 
C3          GATTTCTGCCAAAGTATCTGACCTTATTCTTCCCTCAGCAATGATTTATGAAAAATGGGG 113 
            ************************************************************ 
 
napA        CTCTTACGGTAATGCCGAGCGAAGAACACAACACTGGAGACAGCAAGTCTTACCTGTTGG 1920 
C42         CTCTTACGGTAATGCCGAGCGAAGAACACAACACTGGAGACAGCAAGTCTTACCTGTTGG 179 
            ************************************************************ 
C3          CTCTTACGGTAATGCCGAGCGAAGAACACAACACTGGAGACAGCAAGTCTTACCTGTTGG 173 
            ************************************************************ 
 
napA        CGATGCGATGAGCGATACATGGCAGTGGGTTGAACTTTCAAAACGCTTTACGATTAAAGA 1980 
C42         CGATGCGATGAGCGATACATGGCAGTGGGTTGAACTTTCAAA-CGCTTTACGATTAAAGA 238 
            ****************************************** ***************** 
C3          CGATGCGATGAGCGATACATGGCAGTGGGTTGAACTTTCAAAACGCTTTACGATTAAAGA 233 
            ************************************************************ 
 
napA        CGTGTGGGGTGAGCAACCGATTAAAGGTGGCAAGTTACCAAACGTCATTGAAGCGGCAAA 2040 
C42         CGTGTGGGGTGAGCAACCGATTAAAGGTGGCAAGTTACCAAACGTCATTGAAGCGGCAAA 298 
            ************************************************************ 
C3          CGTGTGGGGTGAGCAACCGATTAAAGGTGGCAAGTTACCAAACGTCATTGAAGCGGCAAA 293 
            ************************************************************ 
 
napA        AGCAATGGGCTACAAAGAGACTGACACCATGTATGATGTTCTTTTTGCCACACCATTTGC 2100 
C42         AGCAATGGGCTACAAAGAGACTGACACCATGTATGATGTTCTTTTTGCCACACCATTTGC 263 
            ************************************************************ 
C3          AGCAATGGGCTACAAAGAGACTGACACCATGTATGATGTTCTTTTTGCCACACCATTTGC 353 
            ************************************************************ 
 
napA        AAAACAATTTAAAGCAGATGATGCCATTGGTAAAGGGTTCGATAACAGTGAAGTCTTTGG 2160 
C42         AAAACAATTTAAAGCAGATGATGCCATTGGTAAAGGGTTCGATAACAGTGAAGTCTTTGG 114 
            ************************************************************ 
C3          AAAACAATTTAAAGCAGATGATGCCATTGGTAAAGGGTTCGATAACAGTGAAGTCTTTGG 413 
            ************************************************************ 
 
napA        TGATGCTCGAAAAGTCATGGGCAGTGATGGCAAAGAGTGGACGGGTTATGGCTTCTTTAT 2220 
C42         TGATGCTCGAAAAGTCATGGGCAGTGATGGCAAAGAGTGGACGGGTTATGGCTTCTTTAT 174 
            ************************************************************ 
C3          TGATGCTCGAAAAGTCATGGGCAGTGATGGCAAAGAGTGGACGGGTTATGGCTTCTTTAT 473 
            ************************************************************ 
 
napA        TCAAAAATCGATTTGGGAAGAGTACCGTCAGTTTGGATTAGGACATGGACATGACCTTGC 2280 
C42         TCAAAAATCGATTTGGGAAGAGTACCGTCAGTTTGGATTAGGACATGGACATGACCTTGC 234 
            ************************************************************ 
C3          TCAAAAATCGATTTGGGAAGAGTACCGTCAGTTTGGATTAGGACATGGACATGACCTTGC 533 
            ************************************************************ 
 
napA        AGACTTTGATACGTATCATAAAGTAAGAGGTTTAAAATGGCCTGTTGTGGATGGTAAAGA 2340 
C42         AGACTTTGATACGTATCATAAAGTAAGAGGTTTAAAATGGCCTGTTGTGGATGGTAAAGA 294 
            ************************************************************ 
C3          AGACTTTGATACGTATCATAAAGTAAGAGGTTTAAAATGGCCTGTTGTGGATGGTAAAGA 593 
            ************************************************************ 
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napA        GACCCAATGGCGTTTTAATGCAAAATACGACCCGTATGCTGCAAAAGCAGGCAATGGTGA 2400 
C42         GACCCAATGGCGTTTTAATGCAAAATACGACCCGTATGCTGCAAAAGCAGGCAATGGTGA 354 
            ************************************************************ 
C3          GACCCAATGGCGTTTTAATGCAAAATACGACCCGTATGCTGCAAAAGCAGGCAATGGTGA 218 
            ************************************************************ 
 
napA        TTTTGCTTTCTATGGTGATTTTGCAAAAGCCCTTAAAAAAGGTAACTTAGTAAAACCAAC 2460 
C42         TTTTGCTTTCTATGGTGATTTTGCAAAAGCCCTTAAAAAAGGTAACTTAGTAAAACCAAC 414 
            ************************************************************ 
C3          TTTTGCTTTCTATGGTGATTTTGCAAAAGCCCTTAAAAAAGGTAACTTAGTAAAACCAAC 278 
                             ************************************************************ 
 
napA        CACAGAAGAGACTTATTCACTTAAAAATAAAGCAAAAATCTTCTTTAGACCGTACATGGA 2520 
C42         CACAGAAGAGACTTATTCACTTAAAAATAAAGCAAAAATCTTCTTTAGACCGTACATGGA 82 
            ************************************************************ 
C3          CACAGAAGAGACTTATTCACTTAAAAATAAAGCAAAAATCTTCTTTAGACCGTACATGGA 338 
            ************************************************************ 
 
napA        TCCATGTGAAATGCCAGATCGTGAGTACGATACATGGCTATGTACAGGACGTGTGTTAGA 2580 
C42         TCCATGTGAAATGCCAGATCGTGAGTACGATACATGGCTATGTACAGGACGTGTGTTAGA 142 
            ************************************************************ 
C3          TCCATGTGAAATGCCAGATCGTGAGTACGATACATGGCTATGTACAGGACGTGTGTTAGA 605 
            ************************************************************ 
 
napA        GCACTGGCATAGTGGTACGATGACCATGAGGGTACCTGAACTTTACCGTGCCGTTCCTGA 2640 
C42         GCACTGGCATAGTGGTACGATGACCATGAGGGTACCTGAACTTTACCGTGCCGTTCCTGA 202 
            ************************************************************ 
C3          GCACTGGCATAGTGGTACGATGACCATGAGGGTACCTGAACTTTACCGTGCCGTTCCTGA 665 
            ************************************************************ 
 
napA        AGCGCTTTGCTACATGCACCCAGAAGATGCAAAAGCAAAAGGGTTTAAACAAGGCGATAT 2700 
C42         AGCGCTTTGCTACATGCACCCAGAAGATGCAAAAGCAAAAGGGTTTAAACAAGGCGATAT 262 
            ************************************************************ 
C3          AGCGCTTTGCTACATGCACCCAGAAGATGCAAAAGCAAAAGGGTTTAAACAAGGCGATAT 155 
            ************************************************************ 
 
napA        GATTTGGTTAGAGAGTCGTCGAGGTTCATGTAAAGCCCGTGTTGAAACCAGAGGACGTAA 2760 
C42         GATTTGGTTAGAGAGTCGTCGAGGTTCATGTAAAGCCCGTGTTGAAACCAGAGGACGTAA 322 
            ************************************************************ 
C3          GATTTGGTTAGAGAGTCGTCGAGGTTCATGTAAAGCCCGTGTTGAAACCAGAGGACGTAA 215 
            ************************************************************ 
 
napA        TAGAACGCCTCGTGGATTGGTGTTTGTTCCATGGTTTGATGAGAAGGTTATGATTAATAA 2820 
C42         TAGAACGCCTCGTGGATTGGTGTTTGTTCCATGGTTTGATGAGAAGGTTATGATTAATAA 414 
            ************************************************************ 
C3          TAGAACGCCTCGTGGATTGGTGTTTGTTCCATGGTTTGATGAGAAGGTTATGATTAATAA 523 
            ************************************************************ 
 
napA        AGTCTGCCTTGATGCAACGTGCCCGATTTCAAAACAGACCGATTATAAAAAATGTGCTGT 2880 
C42         AGTCTGCCTTGATGCAACGTGCCCGATTTCAAAACAGACCGATTATAAAAAATGTGCTGT 474 
            ************************************************************ 
C3          AGTCTGCCTTGATGCAACGTGCCCGATTTCAAAACAGACCGATTATAAAAAATGTGCTGT 583 
            ************************************************************ 
 
napA        TAAGCTCTATAAAGCC 
C42         TAAGCTCTATAAAGCC 
            ****************                         
C3          TAAGCTCTATAAAGCC 
            ****************  
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Initial induction experiments 
             Initial induction experiments were performed with C3 and C42 in BL21(DE3) 
and BL21(DE3) pLysS, respectively.  The C3 induction had no visible induced bands.  
The C42 induction had a faintly induced band at about 115 kD (fig 14).  The induction 
was extremely low compared to induction of the control plasmid (pET101/D/lacZ, 
Invitrogen) shown in fig 15. Several possibilities for low induction were investigated, 
including the possibility of codon bias. 
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Figure 15: Induction of control plasmid pET101/D/lacZ.  Lanes: 1=6h induced, 2=6h 
uninduced, 3=5h induced, 4=5h uninduced, 5=4h induced, 6=4h uninduced, 7=3h 
induced, 8=3h uninduced.  There is a very clear, strong induction at ~120 kD.  The 
induction is far greater then that in C42 
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Figure 14: Induction experiment of C42 in BL21(DE3) pLysS. Lanes: 1=3h 
uninduced, 2=3h induced, 3=4h uninduced, 5=4h induced, 6=5h uninduced, 6=5h 
induced, 7=6h uninduced, 8=6h induced.  The bands, indicated with arrows, are 
clearly present, but faint. 
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Analysis of Codon Bias 
 Because S.  barnesii and E. coli are in different classes,  a difference in codon 
usage between the organisms was considered a possible reason for the low expression 
levels in the initial inductions.  To investigate this possibility, the codon composition of 
napA was compared to the codon bias in E. coli strain B.  The comparison was performed 
using the codon usage database from kazusa (http://www.kazusa.or.jp/codon/) based on 
data from the NCBI genbank.  The comparison is shown in figure 15.  The bias is 
significant: 19.4% of the codons in napA occur less than 1% of the time in E. coli 
(colored codons, figure 16), and 4.5% occur less than 0.5% of the time (shown in red, 
figure 16).  Generally, the rare codons are spread throughout the gene, but in several 
places, two of the rarest were clumped together.  Site directed mutagenesis was done to 
alter one of these clumped rare codons, at position 1687.  Mutagenesis was performed, 
and the resulting construct tested.  The sequencing reaction was not very clear, and 
showed a number of mismatches due to a poor sequencing reaction.  A pilot induction 
was performed despite the unclear results.  The samples were TCA precipitated, in 
contrast to the heat denaturation step used previously.  The results are shown in figure 17.  
No induced bands were visible, and the protein bands are less clear than those in the heat 
prepared samples.     
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Figure 16: Rare codon analysis of napA.  The highlighted codons occur less than 1% of 
the time in E. coli. 
 
      1 AAG GCT GCT GGT GAG CAA GCG GAA GCT AAT  
      31 TGG AAA TGG GAT AAG GCT GTT TGC CGT TTC  
      61 TGT GGT ACC GGT TGT GGT ATT ATG GTG GCG  
      91 ACC AAA GAG GGT AAA ATT GTC GCT GTC AAA  
     121 GGT GAT CCA GCC GCT CCC GTC AAT CGT GGA  
     151 CTT AAC TGT ATC AAA GGC TAT TTT AAC GCC  
     181 AAA ATT ATG TAC GGT GCG GAC AGA TTA AAA  
     211 CAA CCC CTT CTT CGT ATG AAC GAT AAA GGT  
     241 GAG TTT GAC AAA AAA GGT CAG TTT AAA CCT  
     271 GTT TCA TGG AAG CGT GCG TTT GAT GAG ATG  
     301 GAA AAA CAC ATC AAA GCA GCA CTT AAA GTG 
     331 GGT GGG CCA GAG GCG ATT GGT GTG TTT GGT  
     361 TCA GGT CAG TAC ACC ATT CAA GAA GGG TAT  
     391 GCG GCT GCT AAG ATG ATG AAG GCT GGT TTT  
     421 CGT GCC AAC GGA ATT GAT CCT AAT GCA CGT  
     451 CAC TGT ATG GCT TCA GCG GTT GCA GGC TTT  
     481 ATG CAA ACC TTT GGT ATT GAT GAG CCA GCA  
     511 GGG TGT TAT GAT GAT ATT GAA ATT ACC GAT  
     541 ACT ATC ATT ACA TGG GGC GCT AAT ATG GCA  
     571 GAG ATG CAC CCG ATT TTA TGG TCA CGT GTG  
     601 AGT GAT AGA AAA CTT ACC TCA CCT GAT CGT  
     631 GTC AAA ATC GTT AAC CTC TCA ACC TAT ACC  
     661 CAC CGC TGT TCT GAC CTT GCG GAC CTT GAA  
     691 ATC ATC TTC TCT CCA AGT ACC GAT TTG GCA  
     721 ATT TGG AAC TAT ATC GCT CGT GAG ATT GTC  
     751 TAC AAT CAT CCA GAA GCG ATT GAT TGG GAT  
     781 TTT GTT AAG AAA AAT ACC ATT TTT ACA ACA  
     811 GGT TTT GCG AAC ATT GGT TAT GGT ATG CGA  
     841 ACC GAG GCT GAG GCT AAA AAA TTA GGC TAT  
     871 TCT GCA AAA GAA CTT GAA GTC ATT AAA AAA  
     901 GAA GAT GCC AAA GTC ATT TCT GAA AAA GAA  
     931 GCT CCA GGT CTT GCA CAC TTA GGT GTC AAA  
     961 GCA GGC GAT GTT ATG AAA ATG GAC AAA GCA 
     991 GAT GCA GCT GGT GCA CAT TGG GAA ATT AGC  
    1021 TTT GAA GAT TTC AAA AAA GCT TTA GAG CCT  
    1051 TAT ACG CTG GAG TAT GTC GCA AAG ATT TCT  
    1081 AAA GGT AAT CCC GAT GAA AAA CTA GAAGAT 
    1111 TTC AAA GTT AAA CTT CAA GAA CTT GCC AAT  
    1141 CTT TAT ATT GAA AAA AAT AGA AAA GTC GTT  
    1171 AGT TTC TGG ACA ATG GGC TTT AAC CAG CAC  
    1201 CAA AGA GGC ACA TGG GTT AAT GAG CAG TCC 
    1231 TAC ATG GTT CAC TTC CTT TTA GGC AAA CAA  
    1261 GCC AAA CCA GGT GAT GGA GCG TTT TCT CTT  
    1291 ACA GGA CAG CCA AGT GCC TGT GGA ACTGCA 
    1321 CGT GAA GTA GGT ACC TTT ACA CAC CGA CTC  
    1351 CCC NCA GAT ATG GAT GTT TCC ATT CCC AAA  
    1381 CAT AGA GAA GTG AGT GAA AAA ATT TGG AAG  
    1411 CTA CCT GCT GGC ACA CTC AAC CCA ATG GGT  
    1441 TAC CAA CAC ATT ATG AAC ATN CAC CGT CAA  
    1471 ATT GAG AGT GGA AAA ATC AAA TTT GCA TGG  
    1501 GTA AAC GTC TGT AAT CCT TAC CAA GAT ACT  
    1531 GCC AAT GCC AAT CAC TGG ATT AAA GCA GCA     
    1561 CGA GAG CTC GAT AAC TTT ATT GTT TGT TCC  
    1591 GAT GCG TAT CCT GGG ATT TCT GCC AAA GTA  
    1621 TCT GAC CTT ATT CTT CCC TCA GCA ATG ATT  
    1651 TAT GAA AAA TGG GGC TCT TAC GGT AAT GCC  
    1681 GAG CGA AGA ACA CAA CAC TGG AGA CAG CAA 
    1711 GTC TTA CCT GTT GGC GAT GCG ATG AGC GAT  
    1741 ACA TGG CAG TGG GTT GAA CTT TCA AAA CGC  
    1771 TTT ACG ATT AAA GAC GTG TGG GGT GAG CAA  
    1801 CCG ATT AAA GGT GGC AAG TTA CCA AAC GTC  
    1831 ATT GAA GCG GCA AAA GCA ATG GGC TAC AAA  
    1861 GAG ACT GAC ACC ATG TAT GAT GTT CTT TTT  
    1891 GCC ACA CCA TTT GCA AAA CAA TTT AAA GCA  
    1921 GAT GAT GCC ATT GGT AAA GGG TTC GAT AAC  
    1951 AGT GAA GTC TTT GGT GAT GCT CGA AAA GTC  
    1981 ATG GGC AGT GAT GGC AAA GAG TGG ACG GGT  
    2011 TAT GGC TTC TTT ATT CAA AAA TCG ATT TGG  
    2041 GAA GAG TAC CGT CAG TTT GGA TTA GGA CAT  
    2071 GGA CAT GAC CTT GCA GAC TTT GAT ACG TAT  
    2101 CAT AAA GTA AGA GGT TTA AAA TGG CCT GTT  
    2131 GTG GAT GGT AAA GAG ACC CAA TGG CGT TTT  
    2161 AAT GCA AAA TAC GAC CCG TAT GCT GCA AAA  
    2191 GCA GGC AAT GGT GAT TTT GCT TTC TAT GGT  
    2221 GAT TTT GCA AAA GCC CTT AAA AAA GGT AAC  
    2251 TTA GTA AAA CCA ACC ACA GAA GAG ACT TAT  
    2281 TCA CTT AAA AAT AAA GCA AAA ATC TTC TTT  
    2311 AGA CCG TAC ATG GAT CCA TGT GAA ATG CCA  
    2341 GAT CGT GAG TAC GAT ACA TGG CTA TGT ACA  
    2371 GGA CGT GTG TTA GAG CAC TGG CAT AGT GGT  
    2401 ACG ATG ACC ATG AGG GTA CCT GAA CTT TAC  
    2431 CGT GCC GTT CCT GAA GCG CTT TGC TAC ATG  
    2461 CAC CCA GAA GAT GCA AAA GCA AAA GGG TTT  
    2491 AAA CAA GGC GAT ATG ATT TGG TTA GAG AGT  
    2521 CGT CGA GGT TCA TGT AAA GCC CGT GTT GAA  
    2551 ACC AGA GGA CGT AAT AGA ACG CCT CGT GGA  
    2581 TTG GTG TTT GTT CCA TGG TTT GAT GAG AAG  
    2611 GTT ATG ATT AAT AAA GTC TGC CTT GAT GCA  
    2641 ACG TGC CCG ATT TCA AAA CAG ACC GAT TAT  
    2671 AAA AAA TGT GCT GTT AAG CTC TAT AAA GCC  
    2701 TAA       
 
              Occurrence per 1000 in E. coli: 
                   2-4.9    5-7.9    8-10
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Figure 17: Induction of mutated construct with TCA precipitation.  
Lane: 1=4h induced, 2=4h uninduced, 3=3h induced, 4=3h uninduced, 
5=2h induced, 6=2h uninduced, 7=1h induced, 8=1h uninduced. 
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Induction in Rosetta of C42 and MK75 
 After the induction of the mutated plasmid, induction in the Rosetta2 cell line was 
attempted.  The Rosetta2 strain contains a BL21 (DE3) pLysS background, with the 
plasmid pRARE, which contains tRNAs for the rare codons AGG/AGA, CGG, CGA, 
GGA, AUA, CUA, and CCC.     
Induction of C42 in Rosetta cells showed a slightly clearer, stronger looking band 
(figure 18).  The induced bands were visible in the samples prepared by boiling whole 
cells in SDS, but not in samples prepared by TCA precipitation (lanes 6-7).  Although the 
band was stronger, the induced band did not approach the strength of the control 
induction. 
The C42 plasmid was then altered by replacing the ampicillin resistance with 
kanamycin resistance and using site directed mutagenesis to convert the first rare codon 
to a common one (see appendix 3 for position).  The resulting construct was called 
MK75. When MK75 was induced in Rosetta cells, the induced band was clearly 
observed.  However, none of these measures increased the induced band to the expected 
induction levels. 
The induced bands from the gel in figure 18 appeared clearly enough to be cut out 
and analyzed with MALDI-MS.  The MALDI was performed by Dr. Paul Reynolds.  
Analysis of the resulting spectra identified the induced protein as β-galactosidase.   
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Figure 18: Induction of C42 in the Rosetta strain.  Lanes: 1=1h uninduced, 2=1h 
induced, 3=2h uninduced, 4=2h induced, 5=3h induced, 6=3h uninduced, 7=3h 
uninduced with TCA precipitation, 8=3h induced with TCA precipitation.  The TCA 
precipitation method gave poor results, but an induced band is clearly visible in the heat-
prepared samples. 
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Western blot analysis of inductions 
 Following the realization that the induced band seen was not NapA, a western blot 
of an induction with C42 from 4-6 hours in Rosetta pLysS cells using an antibody to the 
V5-epitope was performed.  The resulting blot (figure 19) showed very weak expression 
of multiple bands in both the induced and uninduced fractions.  Lanes 10-15 show 
induction of the pET101/D/lacZ control plasmid (Invitrogen) in BL21(DE3) cells.  A blot 
of an induction of C3 in BL21Star (DE3), however, showed stronger bands only in 
induced fractions. 
 
Inductions in different cell lines 
 In order to test efficacy of the cell lines, induction experiments using the construct 
C3 in BL21star (DE3), BL21star(DE3) pLysS, and Rosetta2 pLysS were conducted.  All 
three inductions were harvested at 3 hours, and the resulting samples were blotted with 
the V5 epitope antibody.  The results (figure 20) show a stronger induction in 
BL21star(DE3), a weak induction in BL21star (DE3) pLysS, and a weak non-induced 
expression (present in both induced and uninduced samples) in Rosetta.  Based on these 
results, BL21star (DE3) was used in further experiments. 
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Figure 19: a) Ponceau stain of blot and b) developed western.  Lanes: 
1=C42 4h uninduced, 2=C42 4h induced, 3=C42 5h uninduced, 4=C42 5h 
induced, 4=6h uninduced, 5=6h induced, 7=Rosetta without plasmid, 
8=control 4h undinduced, 9=control 4h induced, 10=control 5h uninduced, 
11=control 5h induced, 12 = control 6h uninduced, 13=control 6h induced.  
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Figure 20: a) Ponceau of blot and b) developed western comparing the different 
BL21(DE3) cell lines. Lane: 1=uninduced BL21 star (DE3), 2=induced BL21 Star 
(DE3), 3=uninduced pLysS, 4=induced pLysS, 5=uninduced Rosetta, 6=induced 
Rosetta, 7-8= uninduced and induced BL21 Star from a previous induction (control). 
a
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Product degradation 
 The multiple bands of expressed protein suggested that the induction product 
might be degrading.  To test this hypothesis, a pulse-chase experiment with 
chloramphenicol was performed.  Cells were induced for 2 hours, and then 
Chloramphenicol was added to a final concentration of 200 µg/ml. The cells were grown 
for another 4 hours, with samples taken at 1 hour, 2 hours, and 4 hours.  The results 
(figure 21) show degradation occurring one hour after chloramphenicol was added, with 
almost total degradation by 4 hours (lanes 5-8).  The control without chloramphenicol, in 
contrast, remained at a steady concentration during the four hours (lanes 1-4). 
      The possibility that performing the induction at a lower temperature might reduce 
degradation was investigated by performing a two hour induction at room temperature.  
The induction levels were low, as might be expected for a short induction at lower 
temperature, but the degradation pattern was unaffected.  
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Figure 21: a) Ponceau of blot and b) developed western of chloramphenicol 
pulse-chase induction of C3 in BL21 Star (DE3).  Lanes: 1-4=no 
chloramphenicol, t=0, 1, 2, 4h; lanes 5-8= chloramphenicol added, t=0, 1, 2, 4h 
a
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Overnight anaerobic induction 
 The effect of performing the degradation anaerobically was investigated using the  
 C3 and MK75 constructs.  The resulting gels and western blots of MK75 are shown in 
figure 21: results with C3 were similar.  No expression is visible in the gel.  The western 
blot shows production of the protein at a low level.  The degradation bands are still 
significant, although the banding pattern is different from that in the aerobic inductions.   
An aerobic induction was also performed on MK74 with 1mM sodium molybdate added 
to the media.  The banding pattern was the same as that for a C3 aerobic induction  
without molybdenum, suggesting that the Mo does not make a difference in anaerobic 
growth. 
 
Nickel Column purification of cell lysate from C3 induction 
 Initial attempts to purify the induced protein using the ProBond protocol from 
Invitrogen was unsuccessful: Western blot analysis showed that no protein remained on 
the column following incubation (figure 22).  The original protocol used a 50 mM 
phosphate buffer with 500mM sodium chloride for purification.  Lowering the salt 
concentration to 100 mM was successful: Figure 23 shows the resulting gel, and figure 24 
shows the western blot.  the first fraction shows band both in the gel and western blot.   
MALDI was performed on 4 bands from the gel by Paul Reynolds, and all were identified  
as contaminating proteins: beta-galactosidase at 116 kD, Pyrvate Dehydrogenase at 99.8 
kD, HSP 90 at 71.4 kD Chaperonin GroEL at 55 kD, and Elongation Factor Tu at 44.8 
kD.  The western blot band are at similar sizes to those seen in the gel: however, they are  
either too weak to visualize using protein staining, or are masked by the contaminants.  
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Figure 22: a) Gel and b) western blot of anaerobic inductions with MK75. Lanes: 
1=16h uninduced, 2=16h induced, 3=18h uninduced, 4=18h induced, 5=24h uninduced, 
6=24h induced, 7-8=C3 uninduced grown in1 mM sodium molybdate, 9=C3 induced (+ 
control), 10=MK75 3h aerobic induced with 1mM sodium molybdate.  
 
 
 
 
 
 
a)                                                       b) 
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Figure 23: ProBond purification of induced C3 lysate,  1=lysate, 2=lysate after 1hr 
column incubation, 3=wash 1, 4=wash 2, 5=fraction 1, 5= fraction 2, 6=fraction 3, 
7=fraction 4, 8=fraction 4.  Very little tagged protein stuck to the column, and all was 
washed off in the first wash. 
 
 
 
Figure 24: Probond purification of induced C3 lysate with 100 mM sodium chloride. 
1=lysate, 2=postcolumn lysate, 3=wash 1, 4= wash 2, 5=wash 3, 6=wash 4, 7=fraction1, 
8=fraction 2, 9=fraction 3, 10=fraction 4. The bands seen in lane 7 are all contaminants. 
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Figure 25: western blot of ProBond purification of C3 induction with 100 mM NaCl 
1=lysate, 2=postcolumn lysate, 3=wash 1, 4=wash 2, 5=wash 3, 6=wash 4, 7=fraction 1 
8=fraction 2, 9=fraction 3, 10=fraction 4, 11=fraction 5, 12=fraction 6. 
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Creation of a construct with the periplasmic signal sequence 
 Because degradation appeared to be the main problem, and proteases are not 
present in the periplasm, there was the possibility that the protein might not be degraded 
if expressed with the signal sequence, which would cause it to be transported to the 
periplasm.  A construct was therefore created that included the periplasmic signal 
sequence.  A forward primer was designed to begin with the napA original start codon.  
The resulting primer, SeNapAF200.3, had a melting temperature of 57.9oC, and was used 
with SeNapAR200.1.  The resulting product is shown in figure 26.   Cloning was 
attempted both with the original PCR reaction and a gel purified product.  Both reactions 
yielded about 200 clones.  Initial screening of 6 of the clones from the gel purified 
reaction with the RedMix protocol showed that none of them had the insert.  50 of the 
clones from the unpurified PCR reaction were screened by pooling into 5 groups of 10 
and doing restriction enzyme analysis.  Three of the groups had fragments of the 
expected size: one of the groups, clones 11-20, was screened individually.  The results 
are shown in figures 27.  Clone 17 had the correct restriction pattern, and was positive for 
the directional PCR reaction.  The PCR reaction with the original primers was extremely 
weak: however, this may have been an error in setting up the reaction, as PCR using 
SeNapAF200.1 was successful.  To test this, the cloning site of C17 was sequenced.  The 
results, shown in figure 28, indicate that the 5’ end of the gene is indeed intact.  Based on 
these results, C17 was used in pilot expression experiments. 
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Figure 26: a) PCR reaction with Ses-3 DNA and b) gel purified reaction.  1=reaction 
with SeNapAF200.2 and SeNapAR200.1 (control), 2=SeNapAF200.3 and 
SeNapAR200.1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
a)                                              b)
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Figure 27: PCR and restriction analysis of clones from impure PCR reaction in 
figure 26.  a) Directional PCR. Lanes: 1=C11, 2=C12, 3=C13, 4=C14, 5=C15, 6=C16, 
7=C17, 8=C18, 9=C19, 10=C20, 11=C3 (control), 12=C42 (control).  Clones 14,17 and 
18 are positive.  b) PCR with original primers. Lanes: 1=C14 with F200.3 2=C14 with 
F200.1, 3=C17 with F200.3, 4=C17 with F200.1, 5=C42 with F200.1 (+control), 6=C42 
with F200.3 (-control).  c) sacI restriction. Lanes: 1=C14, 2=C17.  C14 did not display 
the correct restriction pattern, while C17 did.    
a) 
    b)                                                                           c) 
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NapA           CCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAAT 120 
C17            -------------------------TCCCGCGAAATTAATACGACTCACTATAGGGGAAT 35 
                                        *********************************** 
 
NapA           TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA 180 
C17            TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA 95 
               ************************************************************ 
 
NapA           GGAGCCCTTCACCATGTCGCTTTCAAGAAGAGACTTTCTAAAAACAACTGCCGCTGCTAG 240 
C17            GGAGCCCTTCACCATGTCGCTTTCAAGAAGAGACTTTCTAAAAACAACTGCCGCTGCTAG 155 
               ************************************************************ 
 
NapA           TGCTGCGGCTGCGGTGGGTATTGGTGTACCCGCTGAGCTTAAGGCTGCTGGTGAGCAAGC 300 
C17            TGCTGCGGCTGCGGTGGGTATTGGTGTACCCGCTGAGCTTAAGGCTGCTGGTGAGCAAGC 215 
               ************************************************************ 
 
NapA           GGAAGCTAATTGGAAATGGGATAAGGCTGTTTGCCGTTTCTGTGGTACCGGTTGTGGTAT 360 
C17            GGAAGCTAATTGGCGATGGGACAAATCTGTGTGCCGTTTCTGTGGTACCGGTTGTGGTAT 275 
               *************  ****** **  **** ***************************** 
 
NapA           TATGGTGGCGACCAAAGAGGGTAAAATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGT 420 
C17            TATGGTGGCGACCAAAGAGGGTAAAATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGT 335 
               ************************************************************ 
 
NapA           CAATCGTGGACTTAACTGTATCAAAGGCTATTTTAACGCCAAAATTATGTACGGTGCGGA 480 
C17            CAATCGTGGACTTAAC-------------------------------------------- 351 
               **************** 
 
 
Figure 28: Sequence alignment of C17.  The cloning site is intact, as is the signal 
sequence.  The mismatches present are the same as those in C3 and C42. 
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Induction of C17 in BL21 Star (DE3) cells    
 The pilot expression experiment was conducted using Bl21 Star (DE3) cells in LB 
containing Amp and 1 mM sodium molybdate.  The induction was allowed to proceed for 
5 hrs.  The resulting gel and western blot are shown in figure 29.  The band at 100kD 
appears stronger in the induced fractions: however, as E. coli has many proteins at this 
molecular weight, the band is not isolated.  The western blot clearly shows a dominant 
band at 100 kD, although many degradation products are still present. 
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a) 
 
 
b) 
Figure 29: Induction of C17. a) SDS-PAGE gel and b) western blot with anti V-5 
Lanes: 1=0.5h uninduced, 2=0.5h induced, 3=1h uninduced, 4=1h induced, 5=2h 
uninduced, 6=2h induced, 7=3h uninduced, 8=3h induced, 9=4h uninduced, 10=4h 
induced, 11=5h uninduced, 12=5h induced.  The up regulation of a band at ~100kD is 
clearly visible starting at 3 hrs, indicated by the arrows in the gel. 
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Probond column purification 
 Probond column purification using 100 mM NaCl phosphate buffer was 
performed on a 5 hour induction of C17 using 50 ml of culture.  The resulting western 
blot and gel are shown in figure 30.  The 100kD band in the gel shows up more clearly 
than in the C3 lysate purification (figure 24).  The strongest band in the gel does not show 
up in the western blot, suggesting that it is a contaminating protein, which was confirmed 
by MALDI analysis of the C3 purification.  A significant fraction of the induced protein 
is not binding to the column. 
 The concentration of protein in the fractions was measured using the Bradford 
assay: however, the concentration was below the threshold for accurate detection by the 
assay. 
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     a) 
 
 
    b) 
Figure 30: Probond column purification of C17 a) SDS-PAGE gel and b) western 
blot (b).  1=lysate, 2=postcolumn lysate, 3=wash 1, 4=wash 2, 4=wash 3, 6=fraction 1, 
7=fraction 2, 8=fraction 3, 9=fraction 4. 
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Discussion 
Cloning and sequencing 
 The cloning reactions did not have the high efficiency rates expected of the TOPO 
cloning system.  The reason for the high level of background is most likely impurities in 
the PCR reaction: small pieces of DNA with the CACC cloning end would be preferred 
over the larger complete sequence.   
Despite this low frequency, the two constructs obtained were clearly correct.  
PCR analysis, restriction analysis, and sequencing of the entire construct and promoter 
region indicated that both C3 and C42 had an intact sequence with no mutations that 
would be expected to interfere with expression (i.e. frame shift mutations).  C17 and 
MK75 were not completely sequenced, but PCR analysis, restriction enzyme analysis, 
and sequencing of the 5′ end of the cloning site verified the identity and correct 
orientation of the construct.  The T7 promoter region of all four clones was also 
sequenced: it is intact, with no insertions or deletion that could contribute to reduced 
efficiency. 
The sequencing data suggests that there are several errors in the napA sequence at 
the 5′ end obtained from Genome Atlantic.  The discrepancy between our data and the 
Genome Atlantic data leads to two changes in the protein sequence: an argenine in place 
of a lysine at position 41, and a serine in place of an alanine at position 44.  C3, C42, 
C17, and MK75 all contain the same mismatches, obtained from multiple sequencing 
reactions: we are therefore fairly confident that our data is correct.  C17 represents the 
first amplification of the full napA gene from S. barnesii.  The N-terminal sequence from 
C17 aligns with contig98 from Genome Atlantic (figure 31).  The result of an open  
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Contig98   CTAAGTGATAGAATCTCCTCGTAACTCAAATCAGGAGGTATCGATATGTCGCTTTCAAGA 
C17clone   ---------------------------------------------ATGTCGCTTTCAAGA                       
                                                        *************** 
 
Contig98  AGAGACTTTCTAAAAACAACTGCCGCTGCTAGTGCTGCGGCTGCGGTGGGTATTGGTGTA 
C17clone  AGAGACTTTCTAAAAACAACTGCCGCTGCTAGTGCTGCGGCTGCGGTGGGTATTGGTGTA        
          ************************************************************ 
 
Contig98  CCCGCTGAGCTTAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGCGATGGGACAAATCT 
C17clone  CCCGCTGAGCTTAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGCGATGGGACAAATCT 
          ************************************************************ 
 
Contig98  GTGTGCCGTTTCTGTGGTACCGGTTGTGGTAT-ATGGTGGCGACCAAAGAGGGTAAAATT 
C17clone  GTGTGCCGTTTCTGTGGTACCGGTTGTGGTATTATGGTGGCGACCAAAGAGGGTAAAATT 
          ******************************** *************************** 
 
Contig98  GTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGA 
C17clone  GTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGA 
          ****************************************** 
 
Figure 31: Alignment of C17 with Contig98 from Genome Atlantic.  The single 
additional T present in C17 puts the sequence in frame. 
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reading frame is shown in appendix 4: the protein sequence is complete, with a product of 
the predicted size, indicating that there are no frameshift mutations present.      
 
Expression   
 Initial induction with C3 and C42 did not produce any visible induction in BL21 
Star (DE3) cells induction of C42 in the pLysS strain produced what appeared to be a low 
level induction of a band at ~115 kD.  This band was taken as evidence of plasmid 
induction, and further experiment were aimed at increasing the intensity of this band.    
 We considered codon bias as a possible candidate for the cause of the low 
expression levels.  Although the rare codons have a higher effect when clustered at the 
start of a gene, the sheer number of rare codons in napA seemed sufficient to interfere 
with high expression levels.  Site directed mutagenesis to convert the rare codons to 
common ones is one method of dealing with the problem.  In the case of napA, this 
method was problematic, as the rare codons were distributed relatively evenly throughout 
the gene.  Nevertheless, several mutagenesis attempts were made, the first on one of the 
paired rare codons, and the second on the first rare codon, which is the second codon in 
the construct.   
The site directed mutagenesis reaction generated the correct mutants, based on the 
sequencing data.  It is interesting to note that the primers used were purified only through 
standard desalting, rather than the gel purification called for in the QuickChange 
protocol.  This substitution did not appear to affect the outcome of the reaction: The total 
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transformation efficiency may have been slightly lower, but the mutation was still 
successful in the transformants tested.   
The construct mutated in at the cluster of rare codons, M1.1, did not show a 
visible induction.  However, the samples were prepared using TCA precipitation, rather 
than heat denaturation.  The TCA precipitation did not yield clear gels, which may have 
been the reason the induced band was not visible.   
Rather than continuing induction experiments with the M1.1 clone, we chose to 
use the Rosetta2 pLysS cell strain to address the rare codon problem.  Previous studies 
have been successful in using the Rosetta strain to express proteins with rare codons 
using the T7 expression system (7, 9).  Because induction had been observed in the 
pLysS strain, we chose to use the Rosetta2 strain containing pLysS. 
Two other strategies for raising induction levels were used concurrently with the 
Rosetta strain: mutagenesis of the first rare codon and insertion of kanamycin resistance 
to produce the construct MK75.  Sequencing of the construct indicated that the 
mutagenesis was successful, and replica plating ensured that the transposon containing 
kanamycin had inserted into ampR on the plasmid.  A PCR reaction was also done to 
amplify napA to verify that the sequence did not contain a second transposon. 
When MK75 was induced in Rosetta2, the induced band appeared more clearly 
than in previous experiments.  However, when this band was analyzed using MALDI-
MS, it was identified as β-galactosidase.  Because BL21 is wild type for the lac operon, it 
was capable of producing β-galactosidase in response to IPTG induction. 
This discovery made it clear that the previous conclusions drawn from the 
induction experiments were incorrect.  There was no evidence that any induction had 
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occurred in any cell line with any construct.  It was clearly necessary to use a detection 
method more sensitive than coomassie gels.   
  Because the constructs were designed to preserve the reading frame through the 
end of the gene to express the his tag and V-5 epitope, it was possible to use the anti-V-5 
epitope antibody to detect levels of expression not visible on a gel.  The antibody has not 
been shown to bind to any bacterial sequences, and the western blots of the napA 
inductions verified the specificity of the detection: no cross-linking was observed in 
lysates from cells not containing the plasmid, and the western blot from the control 
plasmid showed extremely low levels of protein in uninduced fractions.   
Blotting experiments of the Rosetta inductions showed very low, non-specific 
expression of multiple fragments containing the V5-epitope.  A comparison of the BL21 
Star (DE3), the pLysS, and the Rosetta strains showed that the BL21 strain had the 
highest induction levels, while expression in pLysS was extremely low, Rosetta 
expression appeared to be at about the level of the pLysS strain in both the induced and 
the uninduced fractions.  The lowered induction levels in pLysS expected, as the strain 
contains T7lysozyme.  The reason for non-specific expression in Rosetta remains a 
mystery.  The diagram of the pRARE plasmid from Novagen provides little insight, and 
more detailed information on the Rosetta strain is considered proprietary by the company.   
The presence of multiple bands in the induced fractions suggested that 
degradation of the product, rather than inhibition due to codon bias, might be the 
problem.  This was confirmed through the chloramphenicol pulse-chase experiment: 
chloramphenicol inhibits protein synthesis, so that the fate of protein already present in 
the cell at the time of chloramphenicol addition can be observed over time.  This 
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experiment clearly showed that degradation was occurring in the cell, as the protein was 
produced.  The degradation occurred even when the cells were induced at lower 
temperatures.  Anaerobic induction yielded a different breakdown pattern, but did not 
increase overall expression of the intact protein. 
The possibility that addition of molybdenum in the media might decrease 
degradation was also considered: in the absence of the intact cofactor, it is possible that 
the protein would not fold properly, making it more susceptible to degradation.  
However, induction with molybdenum did not make a difference in the degradation 
pattern of MK75 expressed in BL21.   
To determine whether the presence of the signal sequence affected the 
degradation patter, a construct with the original periplasmic signal sequence was created 
and used in induction experiments.  A single construct, C17, was isolated and shown to 
have the insert in the correct orientation.  The T7 promoter region and 5’ terminus was 
also sequenced, although the rest of the insert was not.   
The pilot inductions of C17 showed visible upregulation of a 100kD band, even in 
coomassie stained gels.  The western blot showed that some degradation was still 
occurring, but that the dominant band was at 100kD.   
Clearly, the signal sequence allowed the protein to be expressed at a higher level.  
One possible reason for this is that most degradation occurs in the cytoplasm of E. coli: 
once the protein is in the periplasm, it will not be degraded.  Another possibility is that 
the signal sequence is necessary for correct protein folding.  A recent study by Chan et al 
(6) showed that the twin argenine motif in the signal sequence may play a part in the 
binding of chaperone proteins in E. coli.  If the same is true for S. barnesii’s napA, it 
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could explain the increase in expression: if the protein does not fold properly without the 
signal sequence, it could be more susceptible to degradation.  Both folding and location 
may play a part in the increased expression levels.   
ProBond Purification 
Initial attempts to purify the product were unsuccessful.  When using the pLysS 
and Rosetta strains, this is not surprising, as there was almost no protein to purify.  The 
initial purification with C3 induction in BL21 showed no binding to the column.  
Lowering the salt concentration in the buffer to 100 mM increased binding of protein.  
However, MALDI analysis showed that all the bands visible on the coomassie gel were 
contaminants.  Based on the western blot analysis, some of the target protein did bind to 
the column, though in very small amounts.  Most of the protein was still present in the 
postcolumn lysate.  The dominant band was about 45kD, very close to the 44 kD protein 
identified as an elongation factor. 
Purification of a C17 induction showed a stronger band a 100kD.  This was the 
dominant band in the western blot. The gel had a band of similar size, which may be the 
target protein.  The dominant band on the corresponding gel, however, was still at ~45 
kD,  which was presumably the elongation factor.  
The reason for the low recovery rate is unclear.  If the protein is in folded form, it 
may be possible that the His tag is not accessible to the column.  This possibility can be 
tested by running the column under denaturing conditions.  If product retention increases, 
this is likely the problem.   
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Future directions 
 Although the expression levels using C17 are considerably higher than those 
observed in the other construct, expression is still relatively low.  It should be possible to 
increase expression by altering the induction parameters: a longer induction time at lower 
IPTG levels may increase the buildup of protein.  Anaerobic expression may also prove 
successful. 
 Insertion of the kanamycin resistance gene into C17 may also be helpful in 
boosting expression: ampicillin is a weak antibiotic, and does not persist in the media for 
long.  This leads to a certain percentage of the cells losing the construct, and lower 
overall expression levels. 
 Expression in a cell line deficient in proteases may prevent some of the 
degradation that is still occurring.  BL21 is already lon-: removing clp, which encoded 
another major protease, would be a possible method for increasing expression levels of 
the intact protein. 
 The purification of the protein also needs to be optimized.  The experiments 
described here yielded a highly contaminated protein, with relatively low recovery rates 
of target protein, based on the western blots.  By optimizing the column conditions, it 
should be possible to increase the purity and yield of the sample.  If induction levels 
remain low, it may be necessary to perform a pre-column purification step, such as 
ammonium sulfate precipitation.  If the his tag is inaccessible due to protein folding, it 
may not be possible to purify the product in native form using the ProBond purification 
system.  In this case, other protein purification techniques would have to be used. 
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 The activity of the expressed protein must also be determined.  Initial activity 
assays on the lysate and purified fractions of C17 were unsuccessful: however, as no 
positive control was performed, the results are inconclusive. 
 The system for site-directed mutagenesis has been developed: once the expression 
and purification of the product has been optimized, mutants can be generated 
QuickChange kit, and the active site can be probed. 
Conclusions 
 The genetic portion of the project was a success.  The entire napA gene from 
Sulfurospirillum barnesii was cloned into the pET101 expression vector, and verified 
through sequencing.  Sequencing primers were designed for all but a small portion of the 
construct.  Site directed mutagenesis was successfully performed on the construct, 
demonstrating that the QuikChange system can be used to alter specific bases in the 
construct. 
 Expression of the cloned product was only partially successful.  Protein was 
expressed and partially purified: however, expression levels were low, and purification 
was incomplete with a low recovery rate and high contamination.  The activity of the 
expressed protein was also not verified.  These issues must be addressed before the 
system can be used to probe the active site using site directed mutagenesis.  
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Appendix 1 
 
Organisms with a NapA homologue.  The list was compiled from the NCBI database 
using the tblastn search tool.  The search was performed on May 27, 2007.   
 
Bacteria 
alphaproteobacteria 
• Caulobacterales 
o Caulobacteraceae 
 Caulobacter crescentus  
• Rhizobiales 
o Bradyrhizobiaceae 
 Bradyrhizobium sp. BTAi1 
 Bradyrhizobium sp. ORS278 
 Bradyrhizobium japonicum 
 Rhodopseudomonas Sp. 
o Rhizobiaceae 
 Agrobacterium tumefaciens 
 Sinorhizobium meliloti 
o Phyllobacteriaceae 
 Mesorhizobium loti 
• Rhodobacterales  
o Rhodobacteraceae 
 Rhodobacter capsulatus 
 Rhodobacter sphaeroides 
 Roseobacter denitrificans 
 Paracoccus denitrificans 
• Rhodospirillales 
o Rhodospirillaceae 
 Magnetospirillum magneticum 
 Magnetospirillum magnetotacticum 
 
 
β-proteobacteria 
• Burkholderiales 
o Alcaligenaceae 
 Bordetella bronchiseptica 
 Bordetella parapertussis 
o Burkholderiaceae 
 Burkholderia cenocepacia  
 Burkholderia cepacia 
 Burkholderia mallei 
 Burkholderia pseudomallei 
 Burkholderia thailandensis 
 Burkholderia vietnamiensis  
 Burkholderia xenovorans 
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 Cupriavidus necator (Ralstonia eutropha) 
 Cupriavidus metallidurans (Ralstonia metallidurans) 
• Methylophilales 
o Methylophilaceae 
 Methylobacillus flagellatus 
• Rhodocyclales 
o Rhodocyclaceae 
 Azoarcus sp. BH72 
 Dechloromonas aromatica 
 
 
γ-proteobacteria 
• Aeromonadales 
o Aeromonadaceae 
 Aeromonas hydrophila subsp. hydrophila 
 Aeromonas salmonicida subsp. Salmonicida 
• Alteromonadales 
o Alteromonadaceae 
 Saccharophagus degradans 
o Colwelliaceae 
 Colwellia psychrerythraea 
o Psychromonadaceae 
 Psychromonas ingrahamii 
o Shewanellaceae 
 Shewanella amazonensis 
 Shewanella sp. ANA-3 
 Shewanella baltica 
 Shewanella denitrificans 
 Shewanella frigidimarina 
 Shewanella loihica 
 Shewanella oneidensis 
 Shewanella putrefaciens 
• Enterobacteriales 
o Enterobacteriaceae 
 Erwinia carotovora  
 Escherichia coli 
 Salmonella enterica  
 Salmonella typhimurium 
 Shigella boydii 
 Shigella dysenteriae 
 Shigella flexneri 
 Shigella sonnei 
 Yersinia enterocolitica 
 Yersinia pseudotuberculosis 
 Yersinia pestis  
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• Oceanospirillales 
o Hahellaceae 
 Hahella chejuensis 
• Pasteurellales 
o Pasteurellaceae 
 Actinobacillus pleuropneumoniae 
 Aggregatibacter actinomycetemcomitans 
 Haemophilus ducreyi 
 Haemophilus influenzae 
 Haemophilus somnus 
 Mannheimia succiniciproducens 
 Pasteurella multocida 
• Pseudomonadales 
o Moraxellaceae 
 Acinetobacter sp. YY-5 
o Pseudomonadaceae 
 Pseudomonas aeruginosa 
 Pseudomonas mendocina 
 Pseudomonas stutzeri 
• Thiotrichales 
o Piscirickettsiaceae 
 Thiomicrospira crunogena  
• Vibrionales 
o Vibrionaceae 
 Photobacterium profundum 
 Vibrio cholerae 
 Vibrio fischeri 
 Vibrio parahaemolyticus 
 Vibrio vulnificus 
 
 
δ-proteobacteria 
• Desulfovibrionales 
o Desulfovibrionaceae 
 Desulfovibrio desulfuricans 
• Myxococcales 
o Myxococcaceae 
 Anaeromyxobacter dehalogenans 
 
 
ε-proteobacteria 
• Campylobacterales 
o Campylobacteraceae 
 Arcobacter butzlerii 
 Campylobacter coli 
 Campylobacter curvus 
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 Campylobacter concisus 
 Campylobacter fetus subsp. Fetus 
 Campylobacter lari  
 Campylobacter jejuni subsp. Jejuni 
 Campylobacter upsaliensis 
 Sulfurospirillum barnesii SES-3 
o Helicobacteraceae 
 Helicobacter hepaticus 
 Thiomicrospira denitrificans 
 Wolinella succinogenes 
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Appendix 2 
 
A. Ses-3 DNA purification 
 
Lysis buffer  pH 7.5 
50 mM EDTA 
0.1 M NaCl 
 
Tris-buffered phenol 
Mix equal amounts of Tris (1M, desired pH) and phenol.  Mix, and let stand until layers 
are separated.  Discard the upper (aqueous) layer. Repeat twice more, and store under 
Tris buffer. 
 
B. Agarose gels 
 
TAE stock (50X) 500 ml 
121 g Tris 
28.55 ml Glacial Acetic Acid 
9.3 g EDTA (disodium salt) 
to 500 ml with di H2O 
 
To pour gel: 0.8 g agarose/100 ml TAE stock.  Weigh flask, microwave until agarose is 
melted. Bring back up to original weight with di water, let cool to ~45oC.  If required, 
add 2 µl ethidium bromide stock solution (10 mg/ml) (if running small products, do not 
add ethidium bromide: stain gel in ethidium bromide solution after running).  Swirl to 
mix, and pour into mold.  Let solidify at least 40 min.  Run in 1 x TAE buffer. 
 
 
C. media 
 
LB liquid broth, 1 L 
800 mls nanopure water 
10 g tryptone (1%) 
5 g yeast extract (0.5%) 
10 g NaCl (1%) 
 
Mix, and adjust to pH 7.  Bring to 1 L with nanopure water, and autoclave. 
 
LB Agarose plates 
Add 15 g agar to 1 L LB broth.  Autoclave.  Pour when cooled to ~45oC. 
 
Selective media 
Add appropriate antibiotic after autoclaving.  For plates, add just before pouring. 
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Antibiotic Stock Final conc. Dissolved in Volume in media 
Ampicillin (amp) 50 mg/ml 100 µg/ml Ethanol 2 µl/ml 
Kanamycin (kan) 10 mg/ml 20 µg/ml di water 2 µl/ml 
Carbenicillin (cam) 25 mg/ml 25 µg/ml Ethanol  1 µl/ml 
Tetracycline (tet) 25 mg/ml 24 µg/ml  Ethanol  1 µl/ml 
 
Anaerobic media 
Prepare LB broth as described above, and aliquot into anaerobic bottles.  For pilot 
inductions, use small bottles and 10 ml media: for larger inductions use 25 or 50 ml.  
Degas with N2 ~10 minutes, insert blue cap and crimp top, Degas head space for 5 min.  
autoclave.  
Stocks of lactate, DMSO, and sodium molybdate:   
Lactate, 2 M:  
DMSO, 1.4 M: 
Sodium molybdate, 100 µM: 
Filter sterilize, and add 10 µl/ml to anaerobic media 
 
D. Protein minigels 
 
Running buffer, 1x, 1 L: 
800 ml diH2O 
4.5 g Tris 
1 g sodium dodecyl sulfate (lauryl sulfate) 
21.25 g glycine. 
Bring final volume to 1L 
 
Sample buffer 
950 µl Laemmli sample buffer 
50 µl Beta-mercaptoehtanol 
 
Coomassie Stain 
150 ml diH2O 
0.12 g Coomassie Brilliant Blue 
125 ml Methanol 
50 ml Glacial Acetic Acid 
Up to 500 ml diH2O 
 
E. Western blot 
 
Transfer buffer 
700 mls di H2O 
14.4 g glycine 
3.03 g Tris 
100 ml methanol 
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Bring to 1 L with di H2O pH should be 8.3: usually does not need adjusting 
 
Phosphate buffered saline 
1800 mls di H2O     
16 g sodium chloride 
0.4 g sodium phosphate (dibasic) 
2.3 g potassium phosphate (monobasic) 
0.2 g calcium chloride CaCl2·2H2O 
0.3 g magnesium chloride MgCl·6H2O 
    Adjust pH to 7.4.  Bring to 2 L with di H2O 
 
Killer filler, 2 L 
     Solution A: 
10 g casein  
200 ml 0.1 M sodium hydroxide (1N=1M) 
 
    Solution B:  
1800 ml PBS 
10 g BSA 
 
Mix solutions A and B and adjust pH to 7.4. Add: 
0.2 g phenol red 
3.6 g sodium azide 
 
Carbonate buffer, pH 9.8 
800 mls H2O 
8.4 g sodium bicarbonate 
0.2 g magnesium chloride 
Adjust pH to 9.8 
Bring to final volume of 1 L 
 
Tris-buffered saline (TBS) 
9 g NaCl 
6.05 g Tris 
Final volume 1 L with H2O.   
Adjust pH to 7.5 
 
Tween Tris-buffered saline (TTBS) 
1 L TBS 
0.5 ml Tween-20  
Adjust pH to 7.5 
 
Developing solution 
Solution A: 
0.0075 g 5-Bromo-4-chloro-3-indolyl phosphate (BCIP) 
0.5 ml N,N-dimethyl formamide 
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Solution B: 
0.015 g Nitro blue tetrazolim (nitro-BT) 
0.35 ml N,N-dimethyl formamide 
0.15 ml diH2O 
 
Make solutions A and B in separate microfuge tubes.  Combine solutions A and B in 50 
ml carbonate buffer.  Do not store. 
 
 
 
λ phage transduction 
TBMM broth, 1L  
800 ml nanopure water 
10 g tryptone 
5 g NaCl 
Bring volume to 1 L, autoclave, then add: 
0.2% maltose (2 g/L) from filtered stock 
10 mM MgSO4  (2.47 g/L) from filtered stock 
1g/L thiamine from filtered stock 
 
TB1 plates, 500 ml 
400 ml nanopure water 
5 g tryptone 
2.5 g NaCl 
5.5 g Difco agar 
Bring to 500 L with nanopure water 
Autovclave, and pour plates when cooled to ~45oC 
 
Top agar, 500 ml 
400 ml nanopure water 
5 g tryptone 
2.5 g NaCl 
3.5 g agar 
 
TMG buffer, 100 ml 
80 ml nanopure water 
0.12 g Tris base 
0.246 g MgSO4·7H2O 
Bring final volume to 100 ml, autoclave 
 
 
ProBond column purification 
 
Native purification buffer 5x, 400 ml 
350 mls diH2O  
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14 g NaH2PO (250 mM ) 
    g NaCl (500 mM) 
Adjust pH to 8.0.  Bring final volume to 400 ml.  Store at room temperature 
To make 1x solution, dilute 1:5, and adjust pH to 8.0. 
 
Imidazole solutions 
 
Buffer stock solution A (10x) 100 ml 
80 ml diH2O 
2.76 g NaH2PO4 (200 mM) 
29.29 g NaCl (2.5 M) 
Bring to final volume of 100 ml with di H2O 
 
Buffer stock solution B 
80 ml diH2O 
2.84 g Na2HPO4 (200 mM) 
29.29 g NaCl (2.5 M) 
 
Imidazole Stock Solution 
50 ml diH2O 
20.6 g imidazole (3 M) 
8.77 ml stock solution A 
1.23 ml stock solution B 
Adjust pH to 6.0. Bring final volume to 100 ml. 
 
Native wash buffer, 50 ml 
50 ml 1x native purification buffer 
335 µl imidazole stock solution (20 mM final conc.) 
Adjust pH to 8.0. 
 
Native elution buffer, 30 ml 
27.5 ml native purification buffer 
2.5 ml imidazole stock solution (250 mM final conc.) 
Adjust pH to 8.0 
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Appendix 3 
 
napA primers used for amplification and sequencing. Primers in red are exact matches, 
primers in blue are mutagenesis primers. The brackets denote the signal sequence, which 
was removed in the construction of C42 and C3. 
 
   SeNapAF200.3 
      CCAC>>>>>>>>>>>>>>>>>>>>> 
[1 ATGTCGCTTTCAAGAAGAGACTTTCTAAAAACAACTGCCGCTGCTAGTGCTGCGGCTGCGGTGGGTATTGGTGTACCCGC  
         SeNapAF200.2 
          CACCATG>>>>>>>>>>>>>>>>> 
81 TGAGCTT]AAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGAAATGGGATAAGGCTGTTTGCCGTTTCTGTGGTACCGGTT  
     …CCTTCACCATG>>A>>>>>>>>>>>            
        SeNapmutF3&R3 
161 GTGGTATTATGGTGGCGACCAAAGAGGGTAAAATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGACTT  
 
 
241 AACTGTATCAAAGGCTATTTTAACGCCAAAATTATGTACGGTGCGGACAGATTAAAACAACCCCTTCTTCGTATGAACGA  
 
 
321 TAAAGGTGAGTTTGACAAAAAAGGTCAGTTTAAACCTGTTTCATGGAAGCGTGCGTTTGATGAGATGGAAAAACACATCA  
                                                                              SeNapAF202 
                                                                           >>>>>>>>>>> 
401 AAGCAGCACTTAAAGTGGGTGGGCCAGAGGCGATTGGTGTGTTTGGTTCAGGTCAGTACACCATTCAAGAAGGGTATGCG  
                          SeNapAR201       
          >>>>>>>>><<<<<<<<<<<<<<<<<<<< 
481 GCTGCTAAGATGATGAAGGCTGGTTTTCGTGCCAACGGAATTGATCCTAATGCACGTCACTGTATGGCTTCAGCGGTTGC 
                     SeNapAF203 
                     >>>>>>>>>>>>>>>>>>> 
561 AGGCTTTATGCAAACCTTTGGTATTGATGAGCCAGCAGGGTGTTATGATGATATTGAAATTACCGATACTATCATTACAT 
 
  
641 GGGGCGCTAATATGGCAGAGATGCACCCGATTTTATGGTCACGTGTGAGTGATAGAAAACTTACCTCACCTGATCGTGTC  
                                                     SeNapAF204 
                                         >>>>>>>>>>>>>>>>>>>>>> 
721 AAAATCGTTAACCTCTCAACCTATACCCACCGCTGTTCTGACCTTGCGGACCTTGAAATCATCTTCTCTCCAAGTACCGA 
 
 
801 TTTGGCAATTTGGAACTATATCGCTCGTGAGATTGTCTACAATCATCCAGAAGCGATTGATTGGGATTTTGTTAAGAAAA  
        SeNapAF205 
                                          >>>>>>>>>>>>>>>>>> 
881 ATACCATTTTTACAACAGGTTTTGCGAACATTGGTTATGGTATGCGAACCGAGGCTGAGGCTAAAAAATTAGGCTATTCT 
 
  
961 GCAAAAGAACTTGAAGTCATTAAAAAAGAAGATGCCAAAGTCATTTCTGAAAAAGAAGCTCCAGGTCTTGCACACTTAGG 
 
  
1041 TGTCAAAGCAGGCGATGTTATGAAAATGGACAAAGCAGATGCAGCTGGTGCACATTGGGAAATTAGCTTTGAAGATTTCA 
 
  
1121 AAAAAGCTTTAGAGCCTTATACGCTGGAGTATGTCGCAAAGATTTCTAAAGGTAATCCCGATGAAAAACTAGAAGATTTC 
 
  
1201 AAAGTTAAACTTCAAGAACTTGCCAATCTTTATATTGAAAAAAATAGAAAAGTCGTTAGTTTCTGGACAATGGGCTTTAA 
 
  
1281 CCAGCACCAAAGAGGCACATGGGTTAATGAGCAGTCCTACATGGTTCACTTCCTTTTAGGCAAACAAGCCAAACCAGGTG 
                        CjNapF1                                             SeNapAR206 
                       >>>>>>>>>>>>>>>>>>>>>                    <<<<<<<<<<<<<<<<<<<<<< 
1361 ATGGAGCGTTTTCTCTTACAGGACAGCCAAGTGCCTGTGGAACTGCACGTGAAGTAGGTACCTTTACACACCGACTCCCC  
 
 
1441 NCAGATATGGATGTTTCCATTCCCAAACATAGAGAAGTGAGTGAAAAAATTTGGAAGCTACCTGCTGGCACACTCAACCC  
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1521 AATGGGTTACCAACACATTATGAACATNCACCGTCAAATTGAGAGTGGAAAAATCAAATTTGCATGGGTAAACGTCTGTA  
               SeNapAF207 
              >>>>>>>>>>>>>>>>>> 
1601 ATCCTTACCAAGATACTGCCAATGCCAATCACTGGATTAAAGCAGCACGAGAGCTCGATAACTTTATTGTTTGTTCCGAT  
 
>>>>> 
1681 GCGTATCCTGGGATTTCTGCCAAAGTATCTGACCTTATTCTTCCCTCAGCAATGATTTATGAAAAATGGGGCTCTTACGG  
     SeNapmutF1&F2                                                       SeNapAF208 
         >>>>>>>>>>>>>C>C>>>>>>>>>>>>>>>>>>                                     >>>>>>>>> 
1761 TAATGCCGAGCGAAGAACACAACACTGGAGACAGCAAGTCTTACCTGTTGGCGATGCGATGAGCGATACATGGCAGTGGG  
 
          >>>>>>>>> 
1841 TTGAACTTTCAAAACGCTTTACGATTAAAGACGTGTGGGGTGAGCAACCGATTAAAGGTGGCAAGTTACCAAACGTCATT  
 
 
1921 GAAGCGGCAAAAGCAATGGGCTACAAAGAGACTGACACCATGTATGATGTTCTTTTTGCCACACCATTTGCAAAACAATT  
                   SeNapAF209 
                            >>>>>>>>>>>>>>>>>>> 
2001 TAAAGCAGATGATGCCATTGGTAAAGGGTTCGATAACAGTGAAGTCTTTGGTGATGCTCGAAAAGTCATGGGCAGTGATG  
 
 
2081 GCAAAGAGTGGACGGGTTATGGCTTCTTTATTCAAAAATCGATTTGGGAAGAGTACCGTCAGTTTGGATTAGGACATGGA  
                                                                        SeNapAF210     
>>>>>>>>>>>>>>> 
2161 CATGACCTTGCAGACTTTGATACGTATCATAAAGTAAGAGGTTTAAAATGGCCTGTTGTGGATGGTAAAGAGACCCAATG  
 
          >>> 
2241 GCGTTTTAATGCAAAATACGACCCGTATGCTGCAAAAGCAGGCAATGGTGATTTTGCTTTCTATGGTGATTTTGCAAAAG  
 
 
2321 CCCTTAAAAAAGGTAACTTAGTAAAACCAACCACAGAAGAGACTTATTCACTTAAAAATAAAGCAAAAATCTTCTTTAGA  
                                                                SeNapAF211 
>>>>>>>>>>>>>>>>>> 
2401 CCGTACATGGATCCATGTGAAATGCCAGATCGTGAGTACGATACATGGCTATGTACAGGACGTGTGTTAGAGCACTGGCA  
 
          >>> 
2481 TAGTGGTACGATGACCATGAGGGTACCTGAACTTTACCGTGCCGTTCCTGAAGCGCTTTGCTACATGCACCCAGAAGATG  
 
 
2561 CAAAAGCAAAAGGGTTTAAACAAGGCGATATGATTTGGTTAGAGAGTCGTCGAGGTTCATGTAAAGCCCGTGTTGAAACC  
                         SeNapAR11 
                    <<<<<<<<<<<<<<<<<<<<< 
2641 AGAGGACGTAATAGAACGCCTCGTGGATTGGTGTTTGTTCCATGGTTTGATGAGAAGGTTATGATTAATAAAGTCTGCCT  
                                                 SeNapAR200.1        
                                       <<<<<<<<<<<<<<<<<<<<<< 
    2721 TGATGCAACGTGCCCGATTTCAAAACAGACCGATTATAAAAAATGTGCTGTTAAGCTCTATAAAGCCTAA  
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Appendix 4 
 
Open reading frame translation of combined sequences from C3, C42, and C17. 
 
       1 atgtcgctttcaagaagagactttctaaaaacaactgccgctgct 
         M  S  L  S  R  R  D  F  L  K  T  T  A  A  A 
      46 agtgctgcggctgcggtgggtattggtgtacccgctgagcttaag 
         S  A  A  A  A  V  G  I  G  V  P  A  E  L  K 
      91 gctgctggtgagcaagcggaagctaattggcgatgggacaaggct 
         A  A  G  E  Q  A  E  A  N  W  R  W  D  K  A 
     136 gtgtgccgtttctgtggtaccggttgtggtattatggtggcgacc 
         V  C  R  F  C  G  T  G  C  G  I  M  V  A  T 
     181 aaagagggtaaaattgtcgctgtcaaaggtgatccagccgctccc 
         K  E  G  K  I  V  A  V  K  G  D  P  A  A  P 
     226 gtcaatcgtggacttaactgtatcaaaggctattttaacgccaaa 
         V  N  R  G  L  N  C  I  K  G  Y  F  N  A  K 
     271 attatgtacggtgcggacagattaaaacaaccccttcttcgtatg 
         I  M  Y  G  A  D  R  L  K  Q  P  L  L  R  M 
     316 aacgataaaggtgagtttgacaaaaaaggtcagtttaaacctgtt 
         N  D  K  G  E  F  D  K  K  G  Q  F  K  P  V 
     361 tcatggaagcgtgcgtttgatgagatggaaaaacacatcaaagca 
         S  W  K  R  A  F  D  E  M  E  K  H  I  K  A 
     406 gcacttaaagtgggtgggccagaggcgattggtgtgtttggttca 
         A  L  K  V  G  G  P  E  A  I  G  V  F  G  S 
     451 ggtcagtacaccattcaagaagggtatgcggctgctaagatgatg 
         G  Q  Y  T  I  Q  E  G  Y  A  A  A  K  M  M 
     496 aaggctggttttcgtgccaacggaattgatcctaatgcacgtcac 
         K  A  G  F  R  A  N  G  I  D  P  N  A  R  H 
     541 tgtatggcttcagcggttgcaggctttatgcaaacctttggtatt 
         C  M  A  S  A  V  A  G  F  M  Q  T  F  G  I 
     586 gatgagccagcagggtgttatgatgatattgaaattaccgatact 
         D  E  P  A  G  C  Y  D  D  I  E  I  T  D  T 
     631 atcattacatggggcgctaatatggcagagatgcacccgatttta 
         I  I  T  W  G  A  N  M  A  E  M  H  P  I  L 
     676 tggtcacgtgtgagtgatagaaaacttacctcacctgatcgtgtc 
         W  S  R  V  S  D  R  K  L  T  S  P  D  R  V 
     721 aaaatcgttaacctctcaacctatacccaccgctgttctgacctt 
         K  I  V  N  L  S  T  Y  T  H  R  C  S  D  L 
     766 gcggaccttgaaatcatcttctctccaagtaccgatttggcaatt 
         A  D  L  E  I  I  F  S  P  S  T  D  L  A  I 
     811 tggaactatatcgctcgtgagattgtctacaatcatccagaagcg 
         W  N  Y  I  A  R  E  I  V  Y  N  H  P  E  A 
     856 attgattgggattttgttaagaaaaataccatttttacaacaggt 
         I  D  W  D  F  V  K  K  N  T  I  F  T  T  G 
     901 tttgcgaacattggttatggtatgcgaaccgaggctgaggctaaa 
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         F  A  N  I  G  Y  G  M  R  T  E  A  E  A  K 
     946 aaattaggctattctgcaaaagaacttgaagtcattaaaaaagaa 
         K  L  G  Y  S  A  K  E  L  E  V  I  K  K  E 
     991 gatgccaaagtcatttctgaaaaagaagctccaggtcttgcacac 
         D  A  K  V  I  S  E  K  E  A  P  G  L  A  H 
    1036 ttaggtgtcaaagcaggcgatgttatgaaaatggacaaagcagat 
         L  G  V  K  A  G  D  V  M  K  M  D  K  A  D 
    1081 gcagctggtgcacattgggaaattagctttgaagatttcaaaaaa 
         A  A  G  A  H  W  E  I  S  F  E  D  F  K  K 
    1126 gctttagagccttatacgctggagtatgtcgcaaagatttctaaa 
         A  L  E  P  Y  T  L  E  Y  V  A  K  I  S  K 
    1171 ggtaatcccgatgaaaaactagaagatttcaaagttaaacttcaa 
         G  N  P  D  E  K  L  E  D  F  K  V  K  L  Q 
    1216 gaacttgccaatctttatattgaaaaaaatagaaaagtcgttagt 
         E  L  A  N  L  Y  I  E  K  N  R  K  V  V  S 
    1261 ttctggacaatgggctttaaccagcaccaaagaggcacatgggtt 
         F  W  T  M  G  F  N  Q  H  Q  R  G  T  W  V 
    1306 aatgagcagtcctacatggttcacttccttttaggcaaacaagcc 
         N  E  Q  S  Y  M  V  H  F  L  L  G  K  Q  A 
    1351 aaaccaggtgatggagcgttttctcttacaggacagccaagtgcc 
         K  P  G  D  G  A  F  S  L  T  G  Q  P  S  A 
    1396 tgtggaactgcacgtgaagtaggtacctttacacaccgactcccc 
         C  G  T  A  R  E  V  G  T  F  T  H  R  L  P 
    1441 gcagatatggatgtttccattcccaaacatagagaagtgagtgaa 
         A  D  M  D  V  S  I  P  K  H  R  E  V  S  E 
    1486 aaaatttggaagctacctgctggcacactcaacccaatgggttac 
         K  I  W  K  L  P  A  G  T  L  N  P  M  G  Y 
    1531 caacacattatgaacattcaccgtcaaattgagagtggaaaaatc 
         Q  H  I  M  N  I  H  R  Q  I  E  S  G  K  I 
    1576 aaatttgcatgggtaaacgtctgtaatccttaccaagatactgcc 
         K  F  A  W  V  N  V  C  N  P  Y  Q  D  T  A 
    1621 aatgccaatcactggattaaagcagcacgagagctcgataacttt 
         N  A  N  H  W  I  K  A  A  R  E  L  D  N  F 
    1666 attgtttgttccgatgcgtatcctgggatttctgccaaagtatct 
         I  V  C  S  D  A  Y  P  G  I  S  A  K  V  S 
    1711 gaccttattcttccctcagcaatgatttatgaaaaatggggctct 
         D  L  I  L  P  S  A  M  I  Y  E  K  W  G  S 
    1756 tacggtaatgccgagcgaagaacacaacactggagacagcaagtc 
         Y  G  N  A  E  R  R  T  Q  H  W  R  Q  Q  V 
    1801 ttacctgttggcgatgcgatgagcgatacatggcagtgggttgaa 
         L  P  V  G  D  A  M  S  D  T  W  Q  W  V  E 
    1846 ctttcaaaacgctttacgattaaagacgtgtggggtgagcaaccg 
         L  S  K  R  F  T  I  K  D  V  W  G  E  Q  P 
    1891 attaaaggtggcaagttaccaaacgtcattgaagcggcaaaagca 
         I  K  G  G  K  L  P  N  V  I  E  A  A  K  A 
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    1936 atgggctacaaagagactgacaccatgtatgatgttctttttgcc 
         M  G  Y  K  E  T  D  T  M  Y  D  V  L  F  A 
    1981 acaccatttgcaaaacaatttaaagcagatgatgccattggtaaa 
         T  P  F  A  K  Q  F  K  A  D  D  A  I  G  K 
    2026 gggttcgataacagtgaagtctttggtgatgctcgaaaagtcatg 
         G  F  D  N  S  E  V  F  G  D  A  R  K  V  M 
    2071 ggcagtgatggcaaagagtggacgggttatggcttctttattcaa 
         G  S  D  G  K  E  W  T  G  Y  G  F  F  I  Q 
    2116 aaatcgatttgggaagagtaccgtcagtttggattaggacatgga 
         K  S  I  W  E  E  Y  R  Q  F  G  L  G  H  G 
    2161 catgaccttgcagactttgatacgtatcataaagtaagaggttta 
         H  D  L  A  D  F  D  T  Y  H  K  V  R  G  L 
    2206 aaatggcctgttgtggatggtaaagagacccaatggcgttttaat 
         K  W  P  V  V  D  G  K  E  T  Q  W  R  F  N 
    2251 gcaaaatacgacccgtatgctgcaaaagcaggcaatggtgatttt 
         A  K  Y  D  P  Y  A  A  K  A  G  N  G  D  F 
    2296 gctttctatggtgattttgcaaaagcccttaaaaaaggtaactta 
         A  F  Y  G  D  F  A  K  A  L  K  K  G  N  L 
    2341 gtaaaaccaaccacagaagagacttattcacttaaaaataaagca 
         V  K  P  T  T  E  E  T  Y  S  L  K  N  K  A 
    2386 aaaatcttctttagaccgtacatggatccatgtgaaatgccagat 
         K  I  F  F  R  P  Y  M  D  P  C  E  M  P  D 
    2431 cgtgagtacgatacatggctatgtacaggacgtgtgttagagcac 
         R  E  Y  D  T  W  L  C  T  G  R  V  L  E  H 
    2476 tggcatagtggtacgatgaccatgagggtacctgaactttaccgt 
         W  H  S  G  T  M  T  M  R  V  P  E  L  Y  R 
    2521 gccgttcctgaagcgctttgctacatgcacccagaagatgcaaaa 
         A  V  P  E  A  L  C  Y  M  H  P  E  D  A  K 
    2566 gcaaaagggtttaaacaaggcgatatgatttggttagagagtcgt 
         A  K  G  F  K  Q  G  D  M  I  W  L  E  S  R 
    2611 cgaggttcatgtaaagcccgtgttgaaaccagaggacgtaataga 
         R  G  S  C  K  A  R  V  E  T  R  G  R  N  R 
    2656 acgcctcgtggattggtgtttgttccatggtttgatgagaaggtt 
         T  P  R  G  L  V  F  V  P  W  F  D  E  K  V 
    2701 atgattaataaagtctgccttgatgcaacgtgcccgatttcaaaa 
         M  I  N  K  V  C  L  D  A  T  C  P  I  S  K 
    2746 cagaccgattataaaaaatgtgctgttaagctctataaagcctaa 2790 
         Q  T  D  Y  K  K  C  A  V  K  L  Y  K  A  * 
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Appendix 5: table of vectors, constructs, and cell lines 
 
Table 2: Vectors and bacterial host strains used. Parenthesis indicate official 
designation. 
  
Vectors: Characteristics: Source: 
pET101/D/TOPO T7 promoter, cloning site Invitrogen
C42 (PLB1) napA -signal sequence pET101 
C3 (PLB2) napA -signal sequence pET101 
MK75 (PLB1.1) C42; kanR, first rare codon mutatation C42 
M1.1   (PLB1.3) C42 codon at 1687 mutated  
C17     (PLB4) napA +signal sequence pET101 
Host Strains: Genotype: Source: 
BL21Star(DE3) F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) Invitrogen
BL21Star(DE3)  pLysS F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) 
pLysS 
Invitrogen
 
Rosetta2 pLysS 
 
F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) 
pLysS pRare 
Novagen 
 
Top10 
 
 
F-mcrA∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 
∆lacX74 recA1 araD139 ∆(ara-leu)7697 galU 
galK rpsL (StrR) endA1 nupG 
Invitrogen
 
 
LE392 λNK1105 permissive Trun Lab 
Phage: Genotype: Source: 
λNK1105 λcI857 b522 Pam80 ∆kan ptac-rtnpase Trun lab 
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